Washington University in St. Louis

Washington University Open Scholarship
Arts & Sciences Electronic Theses and
Dissertations

Arts & Sciences

Summer 8-15-2017

DNA Replication Challenges: Telomeres and R loops
Shankar Parajuli
Washington University in St. Louis

Follow this and additional works at: https://openscholarship.wustl.edu/art_sci_etds
Part of the Biochemistry Commons

Recommended Citation
Parajuli, Shankar, "DNA Replication Challenges: Telomeres and R loops" (2017). Arts & Sciences Electronic
Theses and Dissertations. 1209.
https://openscholarship.wustl.edu/art_sci_etds/1209

This Dissertation is brought to you for free and open access by the Arts & Sciences at Washington University Open
Scholarship. It has been accepted for inclusion in Arts & Sciences Electronic Theses and Dissertations by an
authorized administrator of Washington University Open Scholarship. For more information, please contact
digital@wumail.wustl.edu.

WASHINGTON UNIVERSITY IN ST. LOUIS
Division of Biology and Biomedical Sciences
Biochemistry

Dissertation Examination Committee:
Sheila A. Stewart, Chair
Peter M. Burgers
Nima Mosammaparast
Alessandro Vindigni
Zhongsheng You

DNA Replication Challenges: Telomeres and R loops
by
Shankar Parajuli

A dissertation presented to
The Graduate School
of Washington University in
partial fulfillment of the
requirements for the degree
of Doctor of Philosophy

August 2017
St. Louis, Missouri

© 2017, Shankar Parajuli

Table of Contents
List of figures…………………………………………………………………………………..iv
Acknowledgment…………………………………………………………………………..…..v
Abstract…………………………………………………………………………………….....viii
Chapter 1: Introduction to DNA replication, repair, and challenges………………….1
Introduction……………………………………………………………………………… 2
1. Eukaryotic DNA replication and DNA damage repair…………………………... 4
1.1 DNA replication
4
1.2 DNA repair
9
2. Telomere biology……………………………………………………………………14
2.1 Telomere structure and proteins
14
2.2 Telomere replication and maintenance
17
2.3 Telomere physiology
22
3. R loops: Structure, proteins, and physiology…………………………………….27
3.1 Structure
27
3.2 R loop proteins
29
3.3 R loop physiology
30
References……………………………………………………………………………...35
Chapter 2: Flap endonuclease 1 limits telomere fragility on the
leading strand…………………………………………………………….…………………..50
Introduction……………………………………………………………………………..51
Experimental Procedures………………………………………….……………….…55
Results………………………………………………………………………………..…63
FEN1 depletion and transcription inhibition induce replication
stress and a DNA
63
Inhibition of transcription exacerbates the telomere fragility
observed upon FEN1 depletion
66
Leading strand-specific telomere fragility is caused by
RNA:DNA hybrids
67
FEN1 flap endonuclease activity is required for limiting
telomere fragility
70
Discussion…………………………………………………………………………...….72
Acknowledgments…………………….………………………………………………..76
References……………………………………………………………………………...89
Chapter 3: Human Ribonuclease H1 resolves R loops and thereby enables
progression of the DNA replication fork……………………………………..……....…..97
Introduction……………………………………………………………………………..98
Experimental Procedures………………………………………….……………..….100
Results………………………………………………………………………………....106

ii

RNH1 contributes to genome stability and preserves
telomere integrity
106
Nuclear RNA:DNA hybrid levels increase upon RNH1 depletion
107
RNH1 depletion results in replication fork slowing and increased
termination and stalling
108
Nuclease activity of RNH1 is required for efficient replication
fork movement
110
Discussion……………………………………………………………………………..112
Acknowledgments…………………….…………………………………………...…114
References…………………………………………………………………...…….…123
Chapter 4: Conclusions and future directions………………….………………..…....128
Conclusions……………………………………………………………………………129
FEN1 limits telomere fragility on the leading strand
129
Human RNH1 limits R loops and facilitates DNA replication
130
Future Directions……………………………………………………………………...131
Structure and physiology of telomere fragility
131
Regulation of RNH1 during DNA replication
134
References…………………………………………………………………...…….…136

iii

List of figures
Chapter 2: Flap endonuclease (FEN1) limits telomere fragility
on the leading strand
Figure 2.1: α-amanitin treatment abrogates expression of mRNAs
with short half lives but does not alter steady-state TERRA levels
Figure 2.2: FEN1 depletion and transcription inhibition induce
replication stress, a DNA damage response, and telomere fragility
Figure 2.3: RNA:DNA hybrids are responsible for FEN1 depletioninduced leading strand-specific telomere fragility
Figure 2.4: RNA:DNA hybrids are responsible for α-amanitininduced telomere fragility
Figure 2.5: FEN1 flap endonuclease activity is required to
limit leading strand-specific telomere fragility
Figure 2.6: A model of FEN1’s role following co-directional
replisome–RNAP collisions
Chapter 3: Human ribonuclease H1 limits R loops and facilitates
DNA replication
Figure 3.1. RNH1 contributes to genome stability and preserves
telomere integrity
Figure 3.2. Nuclear RNA:DNA hybrid levels increase upon RNH1
depletion
Figure 3.3. RNH1 depletion results in replication fork slowing and
increased termination and stalling
Figure 3.4. Nuclease activity of RNH1 is required for efficient
replication fork movement

iv

77
80
81
83
86
87

115
117
119
121

Acknowledgments
First and foremost, I thank my mentor, Dr. Sheila Stewart, for her guidance and
unwavering support throughout my Ph.D. journey. Since joining her laboratory in January
2012, she has served as a valuable mentor and helped me become the scientist that I am
today. I always felt welcomed by her open-door policy and that encouraged me to stop by
her office to ask any question without having to schedule a meeting. She was always
available when I needed to consult or verify my reasoning as I planned my experiments.
In the meantime, she granted me the freedom and resources to test my ideas and to
become independent. I very much appreciated her balanced approach of mentorship that
has helped me grow and develop both as a scientist and as an adult. One of the most
valuable lessons that Sheila taught was to work hard and learn from my mistakes and
failures; I will treasure this lesson and continue to apply it in my personal and professional
life. I will forever be thankful for her training.

I thank the members of my thesis committee- Dr. Peter M. Burgers, Dr. Nima
Mosammaparast, Dr. Alessandro Vindigni and Dr. Zhongsheng You. Each brought a
unique perspective to my individual and group meetings and pushed me to think critically
and ask tough questions. I offer special thanks to the members of Dr. Vindigni’s group at
Saint Louis University including Jessica Jackson and Dr. Mattero Berti for both teaching
and sharing their reagents.

I am also grateful to the two WashU departments – Department of Biochemistry and
Molecular Biophysics and the Department of Cell biology and Physiology –for providing a

v

resourceful environment to carry out my Ph.D. work. I am thankful to the biochemistry
program coordinators, Melissa Torres, Andrea Krussel, and Stacia Burd, who worked
tirelessly to ensure that I met all the Ph.D. deadlines and filed my paperwork on time. I am
also thankful to the ICCE institute and all its members for providing both a collegial and a
fun environment to work.

My time in graduate school would not have been as rewarding without the support of the
members of the Stewart laboratory. I will forever be grateful to all the lab members, both
past and present. Megan Ruhland, Elise Alspach, and Hayley Moore were thoughtful
scientists and I learned a great deal from interacting with them on a daily basis. I am
especially thankful to Daniel Teasley; he has been a tremendous teacher from my first day
the laboratory. Even after his graduation, Daniel continues to advise me in my post Ph.D.
career plan. I also want to recognize and appreciate Kevin Flanagan who became a close
friend in and outside of the laboratory. I have also found friendship in Bhavna Murali, Yujie
Fu, Xianmin Luo, and Qiaho Ren; they have been responsible for creating a caring lab
environment.

I want to thank all my friends who stood by me and supported as I went through ups and
downs of graduate school. In St. Louis, I was graced with the company of outstanding
individuals including Biva Rajbhandari, Sharad Paudyal, Joo Young Park, Katherine Mann,
Catherine Kuzmicki, Shannon Ohlemacher, John Jimah, Hirak Biswas, Samarth Hegde,
Andrew Chang, Nick Dietrich, and Melissa Li. Each made my living in Saint Louis
enjoyable and full of good memories. I also relished the continued support of my old

vi

friends— Pravin Paudel, Prabin Chandra Subedi, Rashik Adhikari, Ajaya Sharma, Jagat
Adhikari, Rajat Thapa, Dipendra Rokaha, Pradeep Subedi, and Amrit Godar. These
friends have provided unwavering support throughout my life’s successes and challenges.

Lastly, I want to thank my immediate family in Nepal for their unconditional love, support,
and care without which I would not be where I am today. I thank my mom (mommy) and
dad (baba) for instilling good values on me from an early age and for always believing in
me. Their sacrifice is the only reason that I was able to fly to the other side of the world to
obtain the best education. Their teaching that nobody is perfect and that there is always
room to be a better person is what keeps me grounded and motivated every day.
Therefore, I owe all my success to them. I am also forever grateful to my two loving
siblings, my older brother and younger sister. They are my closest friends, biggest
admirers, and greatest critics. Even from afar, they are a constant source of my joy and
happiness.

I am also grateful to the Predoctoral Cancer Biology Pathway Grant from the Siteman
Cancer Center and Barnes Jewish Hospital in Saint Louis for funding portions of my Ph.D.
work.

Shankar Parajuli
Washington University in St. Louis
August 2017

vii

ABSTRACT OF THE DISSERTATION
DNA Replication Challenges: Telomeres and R loops
by
Shankar Parajuli
Doctor of Philosophy in Biology and Biomedical Sciences
Biochemistry
Washington University in St. Louis, 2017
Professor Sheila A. Stewart, Chair

Faithful DNA replication and repair are essential for maintaining genome stability and
preventing various diseases including cancer. Both processes are executed by numerous
redundant mechanisms to ensure that these processes are uninterrupted even when a
primary mechanism fails. Despite this, they are not immune to challenges and failures
leading to DNA damage and genome instability. These problems are more evident at the
difficult-to-replicate regions of the genome such as the telomeres that cap and protect
linear chromosome ends. Additionally, topological structures such as RNA:DNA hybrids,
commonly referred to as R loops, can also present severe challenges to the DNA
replication and repair machineries. Herein we report the functions of two distinct DNA
replication and repair proteins—flap endonuclease 1 (FEN1) and ribonuclease H1
(RNH1)—that preserve genome stability. First, we show that FEN1 limits telomere fragility
in leading strand replicated telomeres. This is mediated by its flap endonuclease activity

viii

independent of its gap endonuclease activity and C-terminal interactions. We show that
the fragility phenotype is increased by RNA polymerase II inhibition and rescued by ectopic
RNH1 expression. Because the telomere is transcribed and can form hybrids, these data
suggest that the FEN1-mediated telomere fragility depends on RNA:DNA hybrids that
accumulate from co-directional replisome-RNAP collision at the leading strand replicated
telomere. These findings are the first to assign a leading strand specific function of FEN1,
which is a canonical lagging strand protein. Second, we uncover a novel role for human
RNH1 in DNA replication in the nucleus. We show that RNH1 depletion results in a global
DNA damage response as well as telomere loss phenotype. Because RNH1 resolves
RNA:DNA hybrids, we measured those hybrid levels and found that they increase upon
RNH1 depletion. Given these hybrids could pose barriers to a moving replication
machinery, we interrogated replication efficiency and discovered that RNH1 facilitates the
replication fork movement, possibly by clearing hybrids. These data shed light onto the
role of RNH1 in global DNA replication. Together, our work underscore the complexity of
DNA replication and repair processes and highlight the varied roles that FEN1 and RNH1
play to maintain genome stability.
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Chapter 1:
Introduction to DNA replication, repair, and challenges
Shankar Parajuli and Sheila A. Stewart
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Introduction
Faithful DNA replication is crucial for maintaining genome stability. This is ensured by
numerous complex and redundant mechanisms aimed at fulfilling various functions during
replication. Redundancy is required to compensate for a function even when a primary
mechanism fails to carry out its designated role. Despite this, replication is not immune to
challenges and failure. For example, variations in genome landscape and architecture
such as regions of high GC content, repetitive sequences, or secondary structures
produce difficult-to-replicate templates increasing the susceptibility to a replication
dysfunction (1), (2). Similarly, DNA replication is also affected by genotoxic and cytotoxic
agents in various forms from use of radiation and chemotherapy to exposure to
environmental insults and food habits. These dysfunctions in DNA replication- either
partial or complete - can lead to genome instability. Such problems are evident in many
diseases including cancer, neurological disorders, and aging syndromes. In fact, these
are the underlying causes of these diseases in many cases. Therefore, understanding
the molecular mechanism of DNA replication, its dysfunction, and its repair is vital to
developing therapies and advancing cures to multiple ailments.

The structure of the genome yields valuable insights into DNA replication process. The
genome in higher eukaryotes is packaged into linear chromosomes to maximize both the
organizational and functional efficiency. Proteins of the histone family play an important
role in this endeavor (3). Furthermore, the linear chromosomes are capped at their termini
by nucleoprotein structures known as telomeres. Telomeres serve multiple functions to
maintain genome stability. First, telomeres prevent chromosome ends from being
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recognized as double strand breaks. Second, they minimize the physical loss of DNA
from end-replication problem that arises from the inability of the lagging strand machinery
to completely replicate the terminal end of a linear chromosome. Third, telomeres regulate
access to replication and repair proteins. Despite a critical role that telomeres play to
protect chromosomal integrity, they pose a significant challenge to the replication
machinery. This is largely due to the G- rich repetitive nature of the sequences that can
form G-quadruplex secondary structures (4). This problem is exacerbated by the absence
of a compensating origin-firing from the opposite direction in the event of a centromeredistal fork collapse leading to a loss of telomere (5). Therefore, several DNA replication
and repair proteins along with the telomere specific proteins play an important role in
minimizing these problems associated with the innately difficult-to-replicate telomere
template.

In addition to a sequence-specific challenges at the telomere, replication machinery also
encounters several topological obstacles throughout the genome. One such challenge is
RNA: DNA hybrids, commonly referred to as R-loops. An R-loop is formed when a
nascent RNA emanating from an RNA polymerase hybridizes with a template DNA
thereby producing a three-strand structure consisting of an RNA bound to a template DNA
and a flanking non-template DNA (6). These structures are formed both at the telomeres
as well as at other regions across the genome at a frequency much higher than previously
appreciated. In recent years, these structures have received renewed interest due to the
diverse and at times opposing cellular roles that they exhibit. While R loops play important
physiological roles in diverse functions including during class switch recombination (CSR)
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and RNA primer generation, they also pose significant threats to genome integrity (7), (8).
Several studies have shown that RNA: DNA hybrids increase the rate of DNA mutation,
DNA recombination, and impairment of replication and transcription (9). Therefore, cells
have developed multiple mechanisms to either prevent or resolve such structures.
Together, the findings that replication machinery faces both a difficult to replicate template
such as a telomere as well as a topological challenge such as an R loop underscore the
need for further investigation into replication process and its efficiency under various
cellular stress to preserve genome stability.

1. Eukaryotic DNA Replication and DNA Damage Repair

1.1 DNA Replication
DNA replication is a fundamental mechanism by which the genome is duplicated during
cell division. The seminal discovery by Watson and Crick in 1953 revealed that the DNA
structure was a double helix with two strands running antiparallel to each other (10).
These findings laid the groundwork for various molecular insights into how DNA
replication occurs. A few years later, an experiment performed by Meselson- Stahl proved
the semi conservative nature of replication whereby a parent DNA strand acts as a
template to produce a daughter strand resulting in a double strand daughter DNA
composed of one old (parent) and one new (daughter) strand (11). In the last 60 years
since, advancement in genetic tools, in-vitro biochemistry, and sequencing has identified
numerous proteins and illuminated a detailed mechanism of DNA replication.
Furthermore, these tools combined with a high-resolution microscopy have offered a
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spatial and temporal insight into DNA replication. In addition to the detailed understanding
of this process, these scientific advancements have allowed discovery and development
of therapies to combat various diseases.

The bulk of the DNA replication occurs during S-phase of the cell cycle and is carried out
in 3 distinct phases: initiation, elongation, and termination. Each of these steps is a
concerted effort of many proteins and is tightly regulated.

Initiation
Initiation of DNA replication begins in G1 and ends in early S-phase of the cell cycle. The
first step of this process is the demarcation of the sites of replication initiation, commonly
referred to as origins of replication. This is initiated by the binding of several proteins
collectively referred to as Origin Recognition Complex (ORC). ORC binding serves as a
platform for recruitment and assembly of Cdc6 (helicase loader), Cdt1 (chaperone), and
the MCM2-7 (replicative helicase) complex, collectively referred to as pre-replication
complex (pre-RC) (1), (12). This facilitates the loading of the helicase activators Cdc45
and GINS to form CMG complex followed by the formation of pre-initiation complex,
initiation of origin DNA unwinding by Mcm10, and subsequent activation of bidirectional
replication forks. In lower eukaryotes such as budding yeast, ORC displays a degree of
sequence specificity but in metazoans such as humans, binding is promiscuous (13), (14).
Because DNA replication can only take place once per cell division, the replication
machinery is under immense pressure to complete replication of the entire genome. This
necessitates many origins to prime replication. As a result, for example, a budding yeast
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genome of about 12 mega base pairs contains about 400 origins whereas a human
genome of about 3 giga base pairs contains between 30,000 and 50,000 origins to
replicate a vast amount of DNA (15).

Elongation
Elongation of DNA replication takes place in S phase of the cell cycle and involves the
addition of deoxyribonucleotides to produce two daughter DNA strands. This process
involves a careful co-ordination between replication initiation proteins and replisome
complex consisting of core proteins including 11- subunit CMG helicase, topoisomerase,
helicase, primase, DNA polymerase a-primase, leading strand polymerase e, lagging
strand polymerase d, RFC clamp loader, Proliferating Cell Nuclear Antigen (PCNA)
clamp, and single strand binding protein RPA (16), (17). Cdc45 plays an important role at
the interface and transition of replication initiation into elongation. As part of the helicase
activating complex, CMG, Cdc45 physically interacts with DNA template and is expected
to play a role in recruitment of the DNA polymerases (18). The high resolution cryo EM
studies of DNA-bound fly CMG and yeast CMG reveal Cdc45 complex structure is similar
to that of Cdc45 crystal structure indicating that the groove inside the CMG complex is
normally blocked and therefore would require further interactions for its opening and fork
movement (19), (20). In fact, in vitro studies have shown that CMG directly interacts with
both leading strand polymerase e and lagging strand polymerase d to maximize their
replication efficiency (21). These findings also highlight an intricate interaction that must
occur with diverse proteins to initiate elongation stage of DNA synthesis. A simpler model
of replication exists in bacteria whereby a duplex DNA is unwound by DNA helicase at
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the leading edge of the replication fork, with replicative DNA polymerase trailing (22). In
eukaryotes, however, this process is complex with a leading strand polymerase anchored
directly on the front of the helicase while the lagging strand polymerase and primase
complex is linked at the back of the helicase (23).

Each DNA double helix consists of two strands- Leading and lagging- that run antiparallel
to each other. Their replications differ on two key fronts. First, because the synthesis of a
new DNA strand can only occur in a 5’ to 3’ direction, DNA replication of a leading strand
(3’-5’ strand) occurs in the direction of replication fork movement and is continuous
whereas that of a lagging strand (5’-3’ strand) occurs in the opposite direction of the
moving fork and is therefore, discontinuous (24). As a result, lagging strand replication
produces DNA fragments (180 and 200 bp in eukaryotes) called Okazaki fragments that
are subsequently processed and joined together by several enzymes including DNA
ligase and Flap endonuclease 1 (FEN1) to generate a new strand. Another significant
difference between the replication of leading and lagging strand involves the utilization of
different DNA polymerases. DNA polymerase e (Pol e) is responsible for bulk of the
leading strand replication whereas DNA polymerases a (Pol a) and d (Pol d) are
responsible for initiation of lagging strand replication and its elongation and maturation
respectively.

DNA replication on both strands is initiated by a 7-10 nucleotide long RNA primer that is
synthesized by DNA polymerase a- primase. Pol a extends these by about 15
deoxynucleotides and hands the replication task over to Pol e and Pol d for replication of
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leading and lagging strands respectively (25). Replication fidelity is key to the massive
task of completing replication of a vast genome. All eukaryotic DNA polymerases can add
between 1000 to 2000 nucleotides of DNA per minute. However, pol e and Pol d have a
much higher fidelity (1 error per 106-107 nucleotide synthesis) compared to Pol a (1 error
per 104- 105 nucleotide synthesis). It is for this reason that the bulk of the replication is
carried out by Pol e and Pol d after initiation by Pol a. The main reason for a lower fidelity
of Pol a is because it lacks the proofreading exonuclease activity that the other two
polymerases e and d possess. DNA replication efficiency of these polymerases is also
enhanced by a clamp loader protein PCNA by increasing their processivities (26).
Replication is tightly regulated to ensure that replication takes place only once during a
cell division. This is ensured by several cell cycle regulatory proteins such as Cdks to
prevent secondary loading at the origin of replication sites.

Termination
DNA replication is terminated by a concerted effort of several proteins. It involves
completion of DNA synthesis, decatenation of daughter DNA strands, and dissociation of
replisome complex. While previous reports suggested that replication termination in
eukaryotes was a result of accumulation of replication forks at the replication pause sites,
it is, however, unclear if forks would stall and eventually terminate at those sites (27).
Recent work suggests that the replicative helicase CMG plays an important role in
termination whereby it is removed from DNA by the ATPase p97 following ubiquitation of
MCM7 (28). This view is also contested because another study has implied that DNA
replication can terminate even in the absence of CMG removal from DNA. To address
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these competing hypotheses of replication termination, Walter’s group utilized in vitro
Xenopus extract system and showed that DNA synthesis does not pause or slow down
as two replication forks converge during termination (29). Instead, leading strands pass
each other unaffected and position next to lagging strands before undergoing ligation.
Moreover, they reveal that CMG helicase remains associated and is removed only after
the ligation of the leading strand of one fork with the lagging strand of the opposite fork
thereby negating a previously proposed model of unloading of CMG as a first step of
termination. In addition, the new model suggests that decatenaton of daughter strands
occurs concurrently with ligation before CMG unloading. According to this model, even if
one fork stalls, it would remain stable until a converging fork arrives to ensure complete
DNA synthesis by minimizing the possibility of premature replisome disassembly.

1.2 DNA Repair
Despite a high fidelity and robust proofreading capabilities of DNA polymerases and a
tight regulation, DNA is not immune to damage that if not repaired can lead to genome
instability. This can result from both internal and external sources such as failure in the
part of replication proteins, natural replication challenges, and exogenous DNA damaging
agents. Therefore, cells have evolved various repair mechanisms to sense such damage
and repair it to ensure that the damaged DNA is not propagated through DNA replication
and cell division. Various DNA repair systems work in tandem with the cell cycle
regulatory machinery to that endeavor. Therefore, when DNA is damaged, DNA
replication is halted and the DNA repair machinery is recruited to the site of the damage.
If the damage is fixed, replication resumes (30). However, if DNA damage is unresolved,
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cells can activate a cell cycle arrest to recruit additional factors to resolve it. In the event
of severe damage or if the repair machinery fails to fix the lesion(s), a cell will either enter
senescence or a programmed cell death to stop the damage propagation.

DNA Damage Response (DDR)
A coordinated cellular response to resolving damaged DNA is called a DNA damage
response (DDR). DDR includes diverse repair systems, each with a task of repairing a
distinct DNA lesion. DNA double strand breaks (DSBs) are the most severe forms of DNA
damage because of their high mutagenic potential (31). Such DNA lesions are repaired
mainly through one of two pathways- homologous recombination (HR) or nonhomologous end joining (NHEJ). HR involves utilization of a homologous template to
recover genetic information that is lost during the initial breakage step or subsequent
processing of DNA. HR initiates with resection of the broken ends from the 5’ to 3’
direction to produce a 3’ single stranded DNA (ssDNA) (32). Initial resection is carried out
by the action of CtIP nuclease in concert with the Mre11, Rad50, and Nbs1 (MRN)
proteins. This is followed by extensive resection by enzymes such as DNA2, which
exposes a long stretch of ssDNA that is then bound by RPA. The function of RPA is to
protect ssDNA from further degradation and recruit Rad51 recombinase to form a
nucleoprotein filament. Once formed, nucleoprotein filaments containing Rad51 along
with several other proteins such as Rad52, BRCA1 and BRCA2 are involved in homology
search, strand invasion, displacement loop (D loop) formation and DNA synthesis to form
a branched nucleic acid structure called a Holliday junction. These structures are then
resolved through either double-strand break repair (DSBR) pathway producing crossover
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products or synthesis-dependent strand annealing (SDSA) producing non-crossover
products. Generally, HR results in non-crossover products to restore parent DNA
sequence.

In contrast to HR, NHEJ is a rapid but an error prone pathway for DSB pathway. It involves
binding of Ku proteins (Ku70/80) to the broken ends followed by end processing and
ligation by DNA ligase 4 (33). DNA protein kinase (DNAPK) plays an important role in
signaling and recruitment of accessory proteins during NHEJ. In cells where NHEJ is
blocked or inhibited, DNA double strand breaks can also be repaired by alternative NHEJ
called micro-homology mediated end joining (MMEJ) (34). MMEJ involves resection or
DNA unwinding to expose short, single strand microhomologies. Such microhomology
sequences are then annealed and DNA repair is completed by cleavage of overhanging
of 3’ flaps, DNA synthesis, and ligation. MMEJ utilizes ligase 1 and ligase 3 instead of
ligase 4. Notably, MMEJ is mutagenic and therefore results in DNA deletions and loss of
genetic information.

In addition to DNA double strand breaks (DSBs), cells encounter several other types of
DNA damage that are processed by distinct repair pathways. For example, ultraviolet
light- induced DNA lesions and bulky DNA adducts are repaired by nucleotide excision
repair (NER) (35). Nucleotide base lesions (single or multiple) are repaired by base
excision repair (BER) whereas base mismatches are fixed by mismatch repair (MMR).
Similarly, DNA crosslinks are repaired by Fanconi anemia (FA) pathway.
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Regulation of the DDR
DDR pathways are subject to tight regulation to ensure repair processes are only active
at the right place and the right time. The regulatory network consists of DNA damage
sensors, signal mediators, signal transducers and signal effectors, all working in tandem
(36). The factors involved in post-translational modifications (PTMs) are a major part of
this network. The most common forms of such modifications are phosphorylation,
ubiquitination, acetylation, methylation, sumoylation and neddylation. In many cases,
these modifications are reversible and therefore are a function of two opposing enzymes.

Among a list of many proteins, two phosphatidylinositol 3-kinase related kinases (PIKKs)ATM (ataxia telangiectasia mutated) and ATR (ATM and Rad3 related)- play a central
role in DDR regulation. Upon DNA damage, the recruitment of the MRN complex to the
DSBs triggers the auto-phosphorylation of ATM at S1981 turning it from an inactive dimer
to an active monomer (37). ATR, on the other hand, is activated in response to replication
stress and replication fork collapse and recruited to the DNA damage site upon binding
of Rad9-Hus1-Rad1 (9-1-1) clamp complex (38). The activation of both ATM and ATR
can lead to the phosphorylation of over 700 downstream substrates that are involved in
various DNA damage responses including DNA repair, cell cycle progression and
apoptosis (39). One of the well-studied substrates of ATM/ATR is histone H2A variant
H2AX. It is an important sensor of DDR and when phosphorylated on S139, referred to
as g-H2AX, it recruits plethora of DDR factors onto a damaged DNA to enact an
appropriate response (40). The regulation of DDR via ATM/ATR is also closely
coordinated with the cell cycle checkpoint kinases, Chk1 and Chk2, which transduce and
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amplify the DDR signal. In fact, ATM directly phosphorylates and activates ChK2 in
response to DSB while ATR phosphorylates Chk1 in response to several other DNA
damages including single strand breaks (41). Additionally, ATM and ATR phosphorylate
master regulator and central tumor suppressor protein, p53, thereby activating the
transcription of several genes that regulate cell cycle arrest, DNA repair, senescence, and
apoptosis (42). The interplay between master regulators of DDR including ATM, ATR,
Chk1, Chk2, and p53 highlight the complexity and redundancy involved in DDR
regulation.

In addition to kinases, several other PTM factors play crucial roles in DDR regulations.
Phosphatases such as WiP1 and PP2A directly regulate the activity of ATM, ATR, DNAPKcs, Chk1, Chk2, and p53 to antagonize the kinase signaling cascades (43). Similarly,
ubiquitin E3 ligases such as RNF8 and RNF168 and deubiquitination (DUBs) enzymes
such as USP, UCH, OUT, and MJD control ubiquitination of H2A histones to regulate
DDR response (44), (45). In addition to ubiquitination, sumoylation is also emerging as a
new mode of regulating DDR via PTM (46).

Aside from PTM factors, non-coding RNAs (ncRNAs) are also evolving as key regulators
of the DDR. This group of ncRNAs includes both the small ncRNAs such as microRNAs
(miRNAs) and small interfering RNAs (siRNAs) as well as long ncRNAs such as XIST
and HOTAIR. miRNAs, for example, are known to directly bind to the 3’UTR of p53 to
disrupt its interaction with Mdm2 following DNA damage (47). Similarly, lncRNAs, for
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example, interact with chromatin remodeling complexes to allow necessary response to
DNA damage.

2. Telomere biology

2.1 Telomere structure and proteins
Telomeres are the nucleoprotein structures that cap the termini of linear chromosomes in
eukaryotes. They consist of telomeric DNA and proteins. Telomeric DNA length varies
between organisms and can range from several hundred base pairs in yeast to tens of
kilobases in mammals.(5) In humans, telomere length is between 5-15 kb whereas that
in lab mouse, it is much longer in the order of 40-50 kb. In mammals, telomeric DNA is
composed of G-rich –TTAGGG- hexanucleotide repeats. Although bulk of the telomeric
DNA is double stranded, mammalian telomeres end with a distinct protrusion of a 50-300
nucleotide single stranded repeats at the 3’end. These 3’ overhangs are called G-tails or
G overhangs (48). By forming a secondary structure commonly referred to as t-loop
(telomeric loop), these 3’ overhangs prevent telomeres from being identified as double
strand breaks.

In addition to the DNA, telomeres consist of many proteins. In mammals, telomeres are
characterized by a basic complex of six proteins, referred together as shelterin complex
(49). The Shelterin complex recognizes the dsDNA and the G-overhang and are
responsible for sheltering telomeres from unwanted activities including the repair
machinery that targets double strand breaks. Furthermore, the shelterin complex is
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involved in facilitating t loop formation at the telomere. The proteins comprising the
shelterin complex are telomeric repeat-binding factor 1 (TRF1), telomeric repeat-binding
factor 2 (TRF2), repressor and activator protein 1 (RAP1), TRF1-interacting nuclear
protein 2 (TIN2), protection of telomeres 1 (POT1), and POT1-and TIN2-interacting
protein (TPP1). TRF1 and TRF2 bind the dsDNA while POT1 binds the single stranded
3’ overhang. TIN2 and TPP1 are linker proteins that hold the complex together. Several
interactions exist amongst these shelterin proteins to form a stable complex to maintain
telomere integrity. For example, TIN2 interacts with TRF1, TRF2 and TPP1 and works as
a lynchpin. TPP1 interacts with TIN2 and POT1 and forms a bridge to hold dsDNA and
single stranded 3’ overhang together. RAP1 interacts with TRF2 to stabilize the complex.
Importantly, all 6 proteins work in a coordinated fashion to ensure the proper replication
and protection of the telomere.

The physiological functions of the shelterin proteins are evident from various in-vitro and
in-vivo studies (5), (50). TRF1 and TRF2 are both essential in mice. In addition,
conditional deletion of either TRF1 or TRF2 results in destabilization of shelterin complex
and telomere deprotection resulting in a telomeric DNA damage response. While they
work as a unit, they also have specific functions during telomere replication. POT1 and
TPP1 work together as a heterodimer, while TPP1 does not bind directly to the telomere,
it is required to localize POT1 to the telomere as POT1 lacks its own nuclear localization
signal. Additionally, TPP1 enhances the telomere-binding efficiency of POT1. POT1/
TPP1 heterodimers execute two major functions at the telomere- protection of 3’ Goverhang and control of telomerase activity. First, by binding to the G-overhang, the
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POT1/TPP1 heterodimer prevents RPA-binding at the G overhang and protect from
activation of an unwanted ATR- mediated DNA damage response. Second, these two
proteins have opposing functions in regulating telomerase activity; POT1 can block
telomerase access to 3’overhang while TPP1 can recruit telomerase and stimulate its
activity. However, how these two opposing activities are coordinated remains unclear.
Another shelterin protein, TIN2, is involved in stabilizing the complex by binding to both
TRF1 and TRF2. It also increases the DNA binding efficiency of both proteins. TIN2interaction with TPP1 is also responsible for facilitating the POT1-TPP1 interaction and
POT1’s binding to the 3’ G-overhang. TIN2 also facilitates the interaction and recruitment
of non-shelterin proteins to the telomere. Notably, TIN2 mutations are found in patients
with short telomeres and those with dyskeratosis congenital. The final shelterin protein,
RAP1, is unique in that it does not directly bind to the telomere DNA but with only TRF2.
Furthermore, it is the only shelterin protein that is not essential in mice. However, its
deletion results in increased recombination without affecting NHEJ or chromosomal
fusions. Its function in humans is predicted to be slightly different from that in mice; it is
expected to function with TRF2 to prevent NHEJ and chromosome fusion. RAP1, like
TIN2, can also recruit or function with non-shelterin proteins, most notably in NFKB
activation.

In addition to the six primary proteins of the Shelterin complex, a growing list of other
telomere-associated proteins have also been identified in mammalian cells. These nonshelterin proteins either aid shelterin proteins or have their own independent functions
during telomere replication, repair, and maintenance. For example, the CST protein
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complex comprising of CTC1, STN1 and TEN1 in mammalian cells and Cdc13, Stn1, and
Ten1 in S. cerevisiae bind to the 3’ overhang and function in telomere protection and
replication (51), (52). Similarly, proteins of the RecQ helicases, WRN and BLM, interact
with members of the shelterin complex and play a role in lagging strand telomere
replication (53), (54). Additionally, our laboratory’s findings demonstrating the role of flap
endonuclease 1 (FEN1) in telomere replication and maintenance highlight the diversity of
non-telomere proteins that are recruited to telomeres (55), (56), (57). In addition to
telomere DNA and proteins, telomeric RNA, commonly referred to as TERRAs, play an
important role in telomere homeostasis either as free or bound to the telomere (58).

2.2 Telomere replication and maintenance
Telomeres must be replicated during S-phase to ensure cell division continuity.
Telomeres are replicated primarily by one of two mechanisms: semi conservative DNA
replication and by the action of the enzyme telomerase. In addition, there are two
specialized mechanisms—recombination-based and alternative lengthening of telomeres
(ALT) –which are activated under certain conditions in distinct cell types to maintain
telomere lengths.

Semi conservative telomere replication and challenges
The most common mode of telomere replication in somatic cells is semi conservative
DNA replication during which telomeres are replicated along with the rest of the genome.
It is a multistep process that involves the movement of replication forks along the
telomeric DNA on both leading and lagging strands followed by the processing of the DNA
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ends to produce a terminal 3’ overhang structure. Replication machinery, however, faces
two major challenges at the telomere compared to other loci in the genome (59). First,
telomere replication is difficult due to its terminal location on the chromosome. While
replication of any other genomic region is carried out by more than one replication forks
originating from different origins, telomeres must be replicated by one centromere-distal
replication fork. This can result in telomeres loss due to replication failure in the event of
a fork collapse or damage. This problem is absent at other regions of the genome
because a compensating replication fork traveling in the opposite direction can at least
theoretically complete replication even when one fork collapses or is no longer functional.
Furthermore, because telomere replication is thought to be initiated from origins located
in the sub-telomeric region, replication machinery is under immense pressure to ensure
that the last fired-origin replicate correctly (60). Failure to do so would result in incomplete
telomere replication. Another major challenge in telomere replication emanates from its
DNA sequence. Telomeres contain G-rich hexanucleotide repeats that form secondary
structures such as G-quadruplexes and T-loops. Such secondary structures need to be
resolved into a linear DNA molecule for replication to occur. While there are mechanisms
for resolution of such structures, this makes DNA replication vulnerable to dysfunction
resulting in incomplete replication or complete loss of telomeres.

Telomere extension by telomerase
Gradual telomere shortening is an inevitable consequence of semi conservative DNA
replication and end-processing. Therefore, cells have evolved a mechanism to extend
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telomeres to restore their lengths and facilitate cell division. This mechanism is a function
of a specialized enzyme called telomerase.

Telomerase is a ribonucleoprotein (RNP) complex comprised of two core subunits:
telomerase RNA (TER) and telomerase reverse transcriptase (TERT) (61). TERT utilizes
TER as a template to synthesize telomeric repeat sequences. While TERs are divergent
in sequence and secondary structures amongst organisms, all TERS contain two
common motifs- template/pseudoknot (PK) and TERT binding CR 4/5 domain. On the
other hand, TERTs are evolutionarily conserved with four domains: the TERT N-terminal
(TEN) domain, the TERT RNA binding domain (TRBD), the Reverse Transcriptase (RT)
domain, and the C-terminal extension (CTE). While the RT and the CTE domains are
conserved between TERT and other reverse transcriptases, TEN and TRBD are unique
to TERT.

Telomerase, like other polymerases, catalyzes the addition of nucleotide to a primer 3’
hydroxyl group. However, telomerase is unique in its ability to interact with both its RNA
template as well as the telomere DNA template. One notable difference is the ability of
telomerase to extend without product dissociation from the enzyme, a process referred
to as repeat addition processivity (RAP) (62). Furthermore, telomerase can copy the 3’
end of the template DNA with less base pairing compared to the 5’ end thereby increasing
its efficiency. Furthermore, telomeric repeats containing RNA, commonly referred to as
TERRA, is believed to play an important role in recruitment of TERT to short telomeres
to facilitate their extension (63).

19

Telomere extension through the action of telomerase is vital during development in
organisms. Therefore, telomerase activity is robust in embryonic stem cells as well as in
somatic cells during development. However, this activity is significantly reduced or absent
in adult human somatic cells (64). This results in progressive shortening of telomeres with
each division in adults. The absence of telomerase in adult somatic cells has both
beneficial as well as deleterious effects. For example, several human diseases including
syndromes of bone marrow failure and pulmonary fibrosis arise from insufficient
telomerase activity (65). In contrast, the absence of telomerase activity is a safeguard
mechanism to preventing cancer as aberrant telomerase reactivation is directly linked to
tumorigenesis (66). Therefore, the function of telomerase in telomere elongation is very
consequential and underscores the importance of understanding its regulation in
multitude of biological processes.

Telomere recombination
In addition to telomere elongation by semi conservative replication and by the action of
telomerase, recombination is a pathway utilized by both yeast and mammals to maintain
telomere length and for survival. Recombination-based telomere length was reported
following an observation that some yeast cells lacking telomerase (est1D) had survived
senescence and formed viable colonies (67). This was corroborated by the fact that
deletion of recombination incompetent cells (rad52D) in est1D delta cells led to loss of all
survivors. In addition to RAD52, all survivor cells require replication protein Pol32p
suggesting that replication is a part of the recombination based telomere maintenance
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(68). These survivor cells are broadly categorized into Type I and Type II (59). Type I
survivors grow slowly and contain multiple Y’ sub telomere repeats and short terminal
telomere repeats. In addition to RAD52 and POL32, type I survivors need RAD51,
RAD54, RAD57, and most likely RAD55 for survival. Type II survivors, on the other hand,
have few sub-telomere repeats but high degree of telomere repeat amplification. Type II
survivors are also a result of type I transformations and require MRX complex, RAD59,
and SGS1 helicase for survival. More recently, recombination based cellular survival in
telomerase-negative cells is proposed to be regulated by TERRA and telomere RNA:
DNA hybrids thereby highlighting the roles of TERRA in telomere homeostasis (69).

Alternative lengthening of telomeres
While 85% of all human cancers have active telomerase for maintaining telomere length
and cell division, the remaining 15% utilize one or more mechanisms referred to as
alternative lengthening of telomeres (ALT) (70). ALT is commonly found in tumors of
mesenchymal origin such as glioblastoma multiforme, osteosarcomas, and some soft
tissue sarcomas (71), (72). ALT cells are identified and characterized based on their
several unique characteristics. One such prominent feature is the presence of telomeric
DNA sequences, as independent DNAs separate from chromosomes. These are found
as double stranded telomeric circles (t-circles), partially single stranded C-rich strands (Ccircles), linear double stranded DNA and t-complex structures with highly branched DNA.
Another distinguishing feature of ALT cells is the presence of telomeric DNA in a subset
of pomelocytic leukaemia nuclear bodies (PML). Such PML bodies are therefore, referred
to as ALT-associated PML bodies and these are believed to play an important role in
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several processes including senescence and DNA damage response. ALT cells are also
marked by high level of telomere recombination and therefore telomere sister chromatid
exchanges (T-SCEs) are abundant in ALT cells. Although still unclear, two current models
exist to explain recombination-dependent telomere elongation in ALT cells. According to
the first model called unequal T-SCE model, unequal T-SCEs occurs between a daughter
cell with a longer telomere and another cell with shorter telomere thereby providing
prolonged proliferative advantage to the cell population. The second model called
homologous recombination-dependent DNA replication, which is a more favorable one
proposes that ALT is a result of shorter telomeres undergoing homologous
recombination-based synthesis. The substrate for telomere elongation, according to this
model, can be a telomere from another chromosome, the same telomere or any linear
extrachromosomal telomeric DNA pieces. Regardless of the model, ALT cells depend on
several DNA replication and repair proteins including the MRN complex and shelterin
complex proteins. Interestingly, a growing body of evidence suggests that telomere RNA
(TERRA) and telomere hybrids play an important role in telomere maintenance in ALT
cells (73).

2.3 Telomere Physiology
Telomeres are indispensable modules for maintaining genome stability. Despite robust
cellular mechanisms aimed at replicating and protecting telomeres, they are not immune
to challenges. Furthermore, gradual telomere attrition due to the “end replication problem’
can produce several consequences in the cell. Some of the most significant
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manifestations are cellular senescence, cell death, and genome instability leading to
several pathologies including cancer and aging disorders.

Cellular senescence and apoptosis
The most prominent consequence of telomere shortening and telomere damage is
cellular senescence. It is a state of irreversible cell growth arrest along with several
physiological changes. Telomere length is a primary determinant of cell division. When a
telomere length reaches a critical length, primarily due to the end replication problem,
commonly referred to as the Hayflick limit, a cell ceases to grow and undergoes growth
arrest (74). Cells also become senescent when they sustain severe damage to the
telomere or any other region of the chromosomes. Cellular senescence has both
desirable as well as deleterious effects depending on the context. While it is a mechanism
to suppress tumorigenesis at times of challenges from DNA damage as well as oncogenic
stimuli, it can also promote pro-tumorigenic effects. Therefore, to prevent cellular
senescence that can result from telomere shortening, cells utilize telomerase. This is a
feature utilized by most cancer cells to achieve immortality. Ectopic expression of
telomerase is also commonly used to immortalize cells for research purpose. However,
telomerase cannot prevent cellular senescence that results in response to oncogenes
such as RAS or DNA damaging agents. Furthermore, inactivation of the tumor suppressor
genes such as p53 and pRb also prevents both human and mice cells from undergoing
senescence in response to DNA damage and oncogenic RAS (75).
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Apoptosis is another consequence of telomere dysfunction. It is a controlled cell death
program activated when a cell sustains irreparable damage. Two tumor suppressors p53
and pRb are critical components controlling the fate of a cell post DNA damage including
post-telomere damage (76). Apoptosis, in many cases, is an alternative to senescence.
For example, when both p53 and pRb are inactive, cells continue dividing until telomeres
are extremely short. Cells at that state enter a phase known as crisis where they sustain
chromosomal instabilities along with telomere attrition, resulting in apoptosis. However,
some cells may still maintain their telomere lengths and hence escape apoptosis; these
cells can proliferate indefinitely but are at a high risk for malignant transformation.

Cancer and genome instability
The importance of telomere maintenance in cancer is underscored by the fact that about
85% of all cancers have activated telomerase and the remaining 15% have the ALT
pathway of telomere elongation (75). Because telomere length can control cell division, a
cancer cell must maintain its telomere length to enable its uncontrolled division to
successfully establish a tumor and later metastasize. Telomerase expression in somatic
cells has provided insights into direct relationship between telomere and cancer. Because
telomerase expression is much higher in mice tissues compared to that in humans, mice
are more cancer-prone than humans. Furthermore, telomerase co-operates with
oncogenic stimuli to promote tumorigenesis as demonstrated by the requirement of
telomerase in immunocompromised mice for tumor formation. Similar observations were
also observed in transgenic mice whereby constitutive expression of telomerase in the
skin promoted skin carcinogenesis (77). In addition, mutations in shelterin proteins are
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well documented in numerous tumors (78). Similarly, numerous DNA replication and
repair proteins including Ku 70/86, and Rad 51 have altered expression changes in
cancers. These direct and indirect roles of telomere proteins in cancer underscore the
significance of telomere protection in preventing tumorigenesis.

Telomere dysfunction is also closely tied to genome instability, which is a hallmark feature
of cancer. In fact, genome instability is a primary cause of many cancers (79). Specifically,
loss of function of DNA replication and repair proteins as well as shelterin proteins are
well-documented in several cases of genome instability and cancer. Telomeres play an
important role in protecting chromosome ends and maintaining genome stability. When
this protection is compromised due to internal and external challenges, chromosomes
become unstable. When severe, it results in loss of genetic material due to chromosome
breakage, fusions, and recombination. This can have deleterious effects including cancer
development and cell death. Telomere dysfunction- caused by telomere shortening,
telomere damage and loss of functions of telomere associated proteins- produces one of
three outcomes for a cell: cellular senescence, cell death, or genome instability. Cellular
senescence is a preferred state adopted by a cell in many cases to avoid genome
instability. This can prevent division of cells with dysfunctional telomeres thereby guarding
against tumor development. However, somatic mutations that accumulate with age can
prevent activation of senescence. This is illustrated by studies showing loss of
heterozygosity and mutations in the p53 tumor suppressor as well as RAS oncogene even
in young and normal tissues (80), (81), (82). These cells fail to activate senescence or
even apoptosis and in turn, result in genome instability that presents an enormous risk
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for neoplastic transformation. A simple mutation or epigenetic change in these cells can
result in transformation.

Aging and non-cancer disorders
Telomere dysfunction is also associated with aging and several other non- cancer
pathologies. The effect of telomere shortening on senescence extends beyond a cell
growth arrest. A senescent cell secretes a whole host of factors that are collectively
referred to as the senescence-associated secretory phenotype (SASP) (83). The SASP
can exert both cell-autonomous and non-autonomous effects and can change tissue
homeostasis by altering cell integrity and function. The effects of SASP factors are studied
in detail in fibroblasts, which are the major component of stroma. Senescent fibroblasts
secrete many factors including enzymes that remodel extracellular matrix, cytokines that
change the immune environment as well as growth factors that dictate cellular
proliferation. These functions of senescent fibroblasts can have either beneficial roles in
tissue homeostasis or detrimental consequences in various pathologies, including
cancer.

The importance of telomere integrity is also reflected by numerous non-cancer diseases.
These diseases arise because of either mutations in specific telomere-related genes or
due to changes in telomere length. Many premature aging syndromes manifest with
mutations in one or more telomere genes. One such example is dyskeratosis congenital
(DC) (84). DC Patients harbor mutations in the components of the telomerase complex
that results in reduced telomerase stability and therefore shorter telomeres. DC is
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classified as either autosomal dominant if mutations affect the TER gene or X-linked if
mutation is on the dyskeratosis congenital 1, dyskerin gene (DKC1). DC patients display
elevated levels of chromosomal instability and develop several pathologies including
abnormal skin pigmentation, short stature, bone marrow failure, hypogonadism and
infertility and premature death. These patients are also predisposed to spontaneous
cancers. Other common premature aging syndromes include ataxia telangiectasia
(mutations in ATM gene), Werner syndromes (mutations in WRN gene) and Bloom
syndromes (mutations in BLM gene) with common features of shorter telomeres and
genome instability. An important point is that patients with some of these premature
syndromes have strikingly different phenotypes compared to the mice models of these
diseases. This presents a challenge in interrogating molecular mechanism of these
pathologies. In addition to diseases resulting from telomere related gene mutations, many
age-related diseases have been identified due to their direct or indirect correlation with
telomere lengths. Some of these disorders include heart failure, digestive tract atrophies,
infertility, reduced angiogenic potential, reduced wound healing, and loss of body mass
(85). Overall, manifestations of telomere dysfunctions through mutations of genes
involved in telomere replication, telomere repair, and telomere maintenance highlight a
diversity of roles telomere plays in genome stability and tissue homeostasis.

3. R loops: Structure, proteins, and physiology

3.1 Structure
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RNA:DNA hybrids, commonly referred to as R-loops, are a three-stranded nucleic acid
structure composed of an RNA-DNA hybrid and a displaced single stranded DNA. While
R loops arise during several biological processes, the most accepted mechanism of R
loop formation is transcription during which a nascent RNA emanating from an RNA
polymerase hybridizes with a template DNA leaving a non-template DNA flanking. In vivo,
R loops are formed as natural intermediates during the initiation of DNA replication in
mitochondria, bacterial plasmids, the bacteriophages ColE1 and T4, and in
immunoglobulin (Ig) class-switch recombination (CRV) (6). Depending on its origin, R
loops can range from 8-10 base pairs to several thousand base pairs in length.

R loop formation depends on three main features: G:C content, DNA supercoiling, and
DNA cleavage (86). Using plasmid constructs in bacteria, it is well-established that
clusters at the non-transcribed strand are required for initiation of R loop formation
whereas the high G density region is required for stabilization and elongation of such
structures. Similarly, negative supercoiling is considered an important factor for R loop
formation in vivo. In fact, high negative superhelicity can reduce the G dependency. A
third element, DNA cleavage or a DNA nick, is an important contributor of R loop formation
based on findings that DNA nicks when placed downstream of the T7 promoter driving
transcription enhanced R loop formation. Because an RNA strand would need to
intertwine with the complementary DNA strand, negative supercoiling and high G content
would make that event favorable by initiation of the bubble between DNA strands. Once
formed, R loop is also favored by the fact that a RNA:DNA hybrid is thermodynamically
more stable than a DNA duplex of identical length.
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3.2 R loop proteins
While naturally occurring R-loops have beneficial roles, undesirable R loop formation and
stabilization have deleterious effects in the cells. Because replication and transcription
occur simultaneously in higher eukaryotes, R loops by virtue of their large topological size
can become a barrier to a moving replication fork as well as transcription apparatus.
Similarly, R loops can induce DNA mutations on non-template DNA as well as increase
the frequency of unwanted recombination (87), (88). Therefore, cells have evolved
numerous mechanisms to either prevent the formation of undesirable R loops or to
process them after their formation. To that end, several nucleases and helicases are
tasked with the removal of R loops and hence prevent their accumulation. Ribonuclease
H1 (RNH1) and ribonuclease H2 (RNH2) are two major nucleases implicated in the
degradation of the RNA component of the hybrid (89). In yeast, both ribonucleases can
resolve R loops and are therefore considered redundant in R-loop resolution. However,
in humans, RNH1 is considered the primary enzyme responsible for R loop resolution
while RNH2 is primarily tasked with the removal of single mis-incorporated ribonucleotide
from DNA during DNA replication. Aside from nucleases, several helicases have also
been identified. In humans, DNA helicase Pif1, RNA helicase DHX9, DNA/RNA helicase
SETX, and RNA helicase AQR have all been shown to resolve R loops; their loss is
associated with accumulation of R loops either in cells or mice models (90), (91), (92),
(93). Similarly, accumulation of negative supercoiling is also associated with R loop
formation. Therefore, enzymes that resolve negative supercoiling are deemed important.
In yeast, cells lacking both topoisomerases Top1 and Top2 accumulate R loops in the

29

ribosomal DNA (rDNA) locus in addition to the stalling of RNA Polymerase and defects in
pre-rRNA synthesis (94). In humans, cells deficient in TOP1 display DNA breaks and
replication defects and these phenotypes are rescued by ectopic expression of RNH1
thereby suggesting that TOP1 prevents R loop accumulation (95). Another mechanism
involved in the prevention of R loop formation is a messenger ribonucleoprotein particle
(mRNP) assembly complex. This involves numerous proteins involved in nascent RNA
synthesis as well as mRNA export machinery. By directly or indirectly binding and
protecting a nascent RNA, mRNP biogenesis proteins prevent its hybridization with the
transcribed DNA strand. The first evidence of the role of mRNP biogenesis in prevention
of R loop formation was provided by yeast studies which showed that yeast cells with a
mutant THO complex, a part of the mRNP biogenesis, led to the accumulation of R loops
(96). Similarly, another mRNP factor, SRSF1, is important for R loop prevention as
evidenced by findings that showed that chicken DT40 and human HeLa cells depleted of
SRSF1 showed elevated levels of rearrangements that were suppressed by RNH1
ectopic expression (97). In addition to mRNP factors, the mRNA surveillance system also
prevents R loop accumulation as evidenced by the increased levels of R loops in yeast
cells depleted of Trf4 as well as in mouse embryonic stem cells depleted of the
exoribonucleases exosome components EXOSC3 and EXOSC10 (98), (99).

3.3 R loops physiology
Recent genome wide analyses have revealed that R loops are present throughout the
genome at a frequency much higher than previously appreciated. Furthermore, it is
becoming increasingly clear that R loops have a wide range of functions in transcription,
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genome dynamics, and chromatin changes. Similarly, they are also implicated in
numerous human diseases including cancer and neurodegenerative diseases.

R loops in transcription
The role of R loops in transcription is evident from genome wide mapping studies. R loops
are present at both the promoter and termination regions of several genes. A genomewide capture of RNA:DNA hybrids followed by sequencing (DRIP-seq) revealed that R
loops are enriched in CpG islands showing a strong GC skew (100), (101). Furthermore,
R loops localize immediately after the transcription start site. Because these sites are hot
spots for the action of gene-silencing DNA methyltransferase 3 B1 (DNMT3B1), R loops
are believed to promote transcription activation of these genes. This hypothesis is also
supported by the fact that regions of high GC skew are bound by methylated histones
such as H3K4me3, H4K20me1 and H3K79me2 linked to transcription initiation and
elongation.

In addition to their roles in transcription activation, R loops are also associated with
transcription termination. High GC skews are present at the 3’ end of some genes and
the incidence of R loops in those regions raises a possibility that R loops are involved in
protection from DNMTs just like in the promoter regions. In doing so, R loops may help
avoid the transcriptional read-through and contribute to termination. In addition, roles of
R loops in transcriptional termination are elucidated from their function in RNA pol II driven
genes. The role of human SETX in XRN2-dependent termination is evidenced by
accumulation of R loops at G rich termination pause sites upon depletion of SETX (92).
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These data suggest that R loops at termination sites are required for RNA pol II pausing
but subsequent removal would allow for release of RNA molecule and efficient
transcription termination.

R loops in genome dynamics
Despite being key intermediates of various processes, R loops can modulate genome
structure by inducing DNA damage and replication stress and by altering telomere
dynamics. In doing so, R loops play an important role in genome instability. A nontemplate DNA strand of an R loop is susceptible to mutations because it is more
accessible to the action of mutagenic enzymes such as activation induced cytidine
deaminase (AID), which can convert cytosine into uracil (102). Furthermore, R loop
mediated DNA breaks, recombination, and chromosome rearrangements have been
demonstrated in yeast and human cells. Because R loops are large topological structure,
most of these DNA damage effects could be a result of the capacity of R loops to stall
replication fork progression. R loops also interfere with the replication process in a
transcription-dependent manner due to the collision of replication and transcription
machineries in either co-directional or head-on directions. Additionally, recent findings
that tumor suppressor proteins BRCA1 and BRCA2 are associated with R loop
homeostasis suggest an expanded role of R loops in DNA repair and replication dynamics
(103).

R loops also play prominent roles at the telomere to protect chromosomal stability.
Telomeric RNA, commonly referred to as TERRAs, hybridize with telomeric DNA to form
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telomeric R loops. These R loops are equally important in both yeast as well as human
cells. These R loops accumulate in yeast strains lacking RNase H or proteins of mRNP
complex such as THO (104). Similarly, R loops play a critical role in maintaining telomeres
in telomerase negative yeast cells whereby R loops activate recombination events that
are necessary for telomere elongation and senescence delay (105). In human cells,
telomeric RNA:DNA hybrids are important in cells that maintain telomere length via ALT
mechanism, which requires R loops to initiate recombination (73). This highlights the
varied roles that telomeric RNA:DNA hybrids play to maintain telomere integrity and
prevent genome instability in yeast and human cells.

R loops in human disease
R loops are associated with numerous human diseases. The neurodegenerative
disorders are one such group that has received a renewed interest. Multiple neurological
disorders are caused by the expansion of trinucleotide repeats. Transcription of CTG
repeats is shown to form R loop both in vitro and in vivo and this is linked to repeat
instability in human cells (106). Similarly, FRDA is another neurological disease caused
by expansion of GAA repeat in the first intron of FXN gene (107). In vitro studies and
those in bacteria have revealed that RNA:DNA hybrids form on GAA repeat sequences
leading to RNA polymerase arrest and reduced transcription of FXN expression. Similar
R loop associated inhibition of transcription are also observed in FXS and fragile X
associated tremor/ataxia syndrome (FXTAS) (108). In addition to direct role of R loops,
R-loop removing enzymes are also implicated in various neurodegenerative disorders.
For example, mutations of helicase SETX is associated with ataxia-ocular apraxia type 2
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(AOA2) and with ALS type 4 (ALS4) (109), (110).

In addition to neurodegenerative disorders, R loops are also important in cancer. This is
largely because R loops are a source of genome instability and replication stress, both of
which are hallmark features of cancer (111). An example of this is the role of tumor
suppressors BRCA1 and BRCA2 in the prevention of R loop accumulation (103). Human
cells depleted of BRCA1 or BRCA2 show elevated levels of R loops as well as double
strand breaks, which are both rescued by ectopic expression of RNH1. In addition, there
are various cancers with mutated R loop related genes whose functions remain unclear.
One such example is a FIP1L1 gene that encodes a cleavage and poly (A) factor; it is
affected by translocations between its amino-terminal domain and platelet-derived growth
factor receptor a (PDGFRa) in 10-20% of eosinophilic leukemia cases (112). Similarly,
another R loop linked protein, splicing factor SRSF1, is also overexpressed in several
cancer types (113). Similar inferences can be made of results from cells infected with the
cancer-causing Kaposi’s sarcoma associated herpesvirus (KSHV) (114). These cells
have elevated DNA damage and increased R loops due to sequestration of RNA export
factor TREX by a viral protein. It is unclear whether these R loop related genes have a
causative link. Regardless, the role of R loops in genome instability and multiple cancers
is undisputed and deserves further investigation.
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Introduction
DNA replication and repair are high-fidelity processes that maintain genome stability.
Due to the importance of these processes, robust mechanisms have evolved to ensure
they are completed even when components of the replication and repair pathways are
compromised or absent due to mutation. In some instances, this compensation is
inadequate. Indeed, mutations in specific replication or repair proteins give rise to
genetic disorders such as ataxia telangiectasia, Bloom syndrome, and Fanconi anemia.
Cells from these patients reveal that while gross DNA metabolism continues largely
unabated, mild replication defects and sensitivity to DNA damaging agents or ionizing
radiation contribute to genomic instability and increased cancer incidence (1,2).

While the redundancy of replication and repair mechanisms ensures faithful replication
of the bulk genome, regions with repetitive sequence or an ability to form secondary
structures are problematic and thus particularly sensitive to mutations in DNA replication
and repair proteins (3). This is best illustrated at common fragile sites, where replication
stressors lead to replication defects and genomic instability. Why particular regions of
the genome manifest as fragile sites remains obscure, but insufficient replication origins,
repetitive sequences, and replication–transcription interference have all been implicated
(4–6).

Recently, telomeres have also been described as fragile sites because treatment with
aphidicolin, a potent inducer of replication stress, results in reduced replication fork
progression and abnormal telomere structures (7,8). In checkpoint-competent
backgrounds, aphidicolin treatment increases telomere fragility by 1.5 to 4.5-fold (7–9),
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while suppression of the ataxia and telangiectasia and Rad3-related (ATR) kinase is
sufficient to induce a 1.7-fold increase in telomere fragility in murine Seckel cells (9).
Telomere fragility is also induced in the absence of telomere-binding proteins that
participate in telomere replication. Indeed, knockout of the Shelterin complex member
TRF1, which is required for replication fork progression through the telomere, increases
the rate of telomere fragility in murine cells by 3.0-to 4.5-fold (7,8,10); similarly,
depletion of the CST complex members CTC1 or STN1, which are important for
replication fork restart at the telomere, causes between a 2.0- and 3.0-fold increase in
telomere fragility in human cells (11).

DNA replication and repair proteins are also important in maintaining telomere stability
by preventing or suppressing telomere fragility. We previously reported that depletion of
flap endonuclease 1 (FEN1) results in a 2.0-fold increase in telomere fragility (12). Loss
of the DNA glycosylase Nth1, which participates in the repair of oxidative stress-induced
lesions, causes a 1.8-fold increase in telomere fragility (13). Helicases and
topoisomerases also play roles in reducing telomere fragility. Depletion of TopoIIα
causes up to an approximately 7-fold increase in telomere fragility, and depletion of the
RecQ helicase BLM induces a 1.9-fold increase in telomere fragility (7,14). Similarly,
RTEL1 depletion or deletion induces 2.3-fold and 4.0-fold increases in telomere fragility,
respectively (7,10). These studies demonstrate the wide range of genetic manipulations
that can induce telomere fragility with varying levels of severity.

The mechanism(s) by which telomere fragility occurs is not clear, but the large number
of proteins implicated in the phenotype suggests that multiple mechanisms exist. G52

quadruplexes may play a role, as telomere fragility induced by RTEL1 deletion is
exacerbated by treatment with the G-quadruplex-stabilizing drug TMPyP4 (10). Given
these data, if the molecular event inducing telomere fragility occurs after the replication
fork has passed, RTEL1-induced telomere fragility would be expected to exhibit lagging
strand specificity; however, few studies have examined strand-specific telomere fragility.
Sfeir et al. examined TRF1 knockout mouse cells using chromosome-orientation
fluorescent in situ hybridization (CO-FISH), which is capable of distinguishing telomeres
replicated by the leading versus lagging strand DNA replication machinery; they found
that telomere fragility induced by loss of TRF1 did not exhibit strand specificity (7).
Similarly, Chawla et al. identified UPF1, an ATPase and helicase associated with
cytoplasmic RNA quality control, as a telomere binding protein; in UPF1-depleted cells,
telomere fragility increased at both the leading and lagging strands, with a slightly larger
increase observed at the leading strand (15). Most recently, Arora et al. demonstrated
that ectopic expression of ribonuclease H1 (RNase H1) reduced fragile telomere
formation on the leading strand in alternative lengthening of telomeres (ALT)-positive
cells (16).

Among the stressors the replisome encounters, transcription has a significant impact on
DNA replication. Indeed, head-on collisions between the replisome and RNA
polymerase (RNAP) are extremely damaging to the replication process (17). In contrast
to head-on collisions, co-directional replisome–RNAP collisions in bacteria are more
common and better tolerated by the cell (18,19). This may be due to a mechanism
recently elucidated in viral and prokaryotic polymerases: following a co-directional
collision with RNAP on the leading strand-replicated DNA, DNA polymerase III is
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removed from the template, moves forward to the 3′ end of the nascent transcript,
displaces RNAP, and restarts DNA synthesis using the transcript as a primer (20).
Despite this mechanism, which would seem to permit damage-free replication across a
region being transcribed, co-directional collisions between the replisome and RNAP can
lead to unresolved RNA:DNA hybrids. If such collisions occur in mammalian cells, the
RNA:DNA hybrids left behind would likely lead to DNA double strand breaks, an ataxia
telangiectasia mutated (ATM)-mediated DNA damage response (DDR), and genomic
instability (21,22). Thus, robust mechanisms would need to evolve to remove the
RNA:DNA hybrids produced by a collision event.

The known role of FEN1 in limiting telomere fragility (12), as well as the idea that
telomere fragility might be the result of replication stress or interference with
transcription, led us to explore the mechanism by which FEN1 reduces telomere
fragility. We show that treatment with α-amanitin, which reduces the rate of RNAP
elongation and thus may increase the rate of stochastic co-directional replisome–RNAP
collisions, exacerbates the telomere fragility induced upon FEN1 depletion. Additionally,
we find that the telomere fragility phenotype induced by FEN1 depletion and collision
induction is RNA:DNA hybrid-dependent by rescuing telomere fragility with ectopic
expression of RNase H1. FEN1’s role in limiting telomere fragility is distinct from its role
in limiting sister telomere loss, as FEN1 depletion-induced telomere fragility is restricted
to the leading strand. Neither FEN1’s classical replication role as mediated by its
interaction with proliferating cell nuclear antigen (PCNA), nor FEN1’s DNA repair
function mediated by its C-terminal interactions with numerous repair proteins are
required for its activity in limiting telomere fragility. We find that FEN1’s gap
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endonuclease and exonuclease activities are also dispensable for limiting telomere
fragility, but that FEN1’s flap endonuclease activity is required. Our data support a
model in which co-directional replisome–RNAP collisions on the leading strandreplicated telomere produce RNA:DNA hybrid/flap structures that accumulate in the
absence of FEN1. We propose that FEN1, a classical lagging strand replication protein,
acts on the leading strand during telomere replication to resolve RNA:DNA hybrid/flap
structures resembling Okazaki fragment substrates; in the absence of this activity, the
subsequent replication stress and DNA damage manifests as telomere fragility. We
believe this to be the first report placing an Okazaki fragment-processing protein
explicitly on the leading strand during DNA replication.

Experimental Procedures
Cell culture
Cells were cultured at 37 °C in 5% carbon dioxide and atmospheric oxygen, as reported
previously (12,23,24). 293T cells and HEK 293 cells were cultured in high-glucose
Dulbecco’s modified Eagle’s medium containing 10% heat-inactivated fetal bovine
serum (ΔFBS) and 1% penicillin/streptomycin (P/S) (Sigma-Aldrich, St. Louis, MO). BJ
fibroblasts and BJ fibroblasts expressing Large T Antigen (BJL) were cultured in highglucose Dulbecco’s modified Eagle’s medium containing 15% Medium 199 (HEPES
modification), 15% ΔFBS, and 1% P/S. RPE1 cells were cultured in Dulbecco’s modified
Eagle’s medium (F12 modification) containing 7.5% ΔFBS and 1% P/S (Sigma-Aldrich,
St. Louis, MO). Treatment with α-amanitin (Sigma-Aldrich, St. Louis, MO) was
performed at 10 µg/mL for 12 hours prior to collection. All cell cultures were verified free
of Mycoplasma contamination by PCR analysis. RPE1 cells were obtained from ATCC;
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all other cells were obtained from Dr. Robert Weinberg (Massachusetts Institute of
Technology).

Virus production and infections
Lentiviral production and transductions were carried out as reported previously (25).
Briefly, 293T cells were transfected with an 8:1 ratio of pHR′-CMV-8.2ΔR packaging
plasmid and pCMV-VSV-G, and a pLKO.1-puro plasmid carrying an shRNA using
TransIT-LT1 (Mirus Bio, Madison, WI). Supernatant-containing virus was collected 48
hours post-transfection and 72 hours post-transfection and filtered through a 0.45-μm
PVDF membrane. Target cells were infected for four hours each on two consecutive
days in the presence of 8 μg/mL protamine sulfate (Sigma-Aldrich, St. Louis, MO).
Following infection, transduced BJ and BJL cells were selected with 1 μg/mL puromycin
sulfate (Sigma-Aldrich, St. Louis, MO); transduced RPE1 cells were selected with 15
μg/mL puromycin sulfate.

Production of recombinant adenovirus type 5 was carried out using the AdEasy
adenoviral vector system (Agilent Technologies, La Jolla, CA) according to the
manufacturer’s protocol. Following collection of primary adenoviral stock, secondary
and tertiary viral stocks were prepared by sequential infection of HEK 293 cells and
purification from a cesium gradient. Briefly, infected cells were lysed in 0.5% Nonidet P40 and cell debris was cleared by centrifugation. Viral particles were precipitated from
the lysate with 6.7% PEG 8000, 0.83 M sodium chloride, collected by centrifugation,
and washed in PBS. Viral particles were suspended in 1.32 g/mL cesium chloride and
centrifuged at 33,000 rpm for 18 hours at 4 °C in a swinging-bucket rotor. Intact viral
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particles were collected from the cesium gradient, dialyzed in PBS, suspended in 33%
glycerol, and frozen. Viral stocks were quantified using the AdEasy viral titer kit (Agilent
Technologies, La Jolla, CA) according to the manufacturer’s instructions.

Adenoviral transduction was carried out following lentiviral transduction. Cells were
lifted, combined with concentrated adenovirus, and re-plated in media containing
puromycin to select for lentiviral integration. Adenovirus was used at a multiplicity of
infection of 20 on RPE1 cells. Following 48 hours of simultaneous selection and
adenoviral infection, the media was replaced.

Western blot analysis
Western blots were conducted as described previously (26). Briefly, cells were washed
with PBS and lysed in mammalian cell lysis buffer (100 mM sodium chloride, 50 mM
tris-HCl pH 8, 5 mM EDTA, 0.5% Nonidet P40) supplemented with 2 mM dithiothreitol, 1
mM Microcystin-LR, 2 mM phenylmethylsulfonyl fluoride, 1 mM sodium fluoride, 1 mM
sodium orthovanadate, protease inhibitor cocktail (Sigma-Aldrich, St. Louis, MO), and
phosphatase inhibitor cocktail set I (EMD Millipore, Billerica, MA). Following
centrifugation, clarified lysate was quantified using the Bio-Rad Protein Assay (Bio-Rad,
Hercules, CA). Lysates were resolved by SDS-PAGE and transferred to PVDF
membranes for western blotting. The following antibodies were used: mouse
monoclonal anti-Chk1 (sc8408, Santa Cruz Biotechnology, Santa Cruz, CA); rabbit
monoclonal anti-Chk1, phospho-S345 (2348, Cell Signaling Technology, Danvers, MA);
rabbit polyclonal anti-FEN1 (A300-255A, Bethyl Laboratories, Montgomery, TX); mouse
monoclonal anti-RNase H1 (H00246243-M01, Novus Biologicals, Littleton, CO); rat
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monoclonal anti-α-tubulin (ab6160, Abcam, Cambridge, UK); mouse monoclonal anti-βcatenin (610154, BD Biosciences, San Jose, CA); rabbit polyclonal anti-γH2AX (07-164,
Millipore, Billerica, MA).

Metaphase chromosome preparation
Metaphase chromosome spreads were prepared as described previously (27). Briefly,
BJ and BJL fibroblasts were cultured in the presence of 0.1 µg/mL colcemid (SigmaAldrich, St. Louis, MO) for five hours; RPE1 cells were cultured in the presence of 0.3
µg/mL colcemid for four hours. Following arrest, metaphase cells were collected by
mitotic shake-off, swollen in 75 mM potassium chloride, and fixed in 3:1 methanol:acetic
acid. Chromosomes were spread by dropping onto glass slides and aged for 18 hours
at 65 °C. When metaphases were to be analyzed by CO-FISH, 0.3 µg/mL of 5-bromo2′-deoxyuridine (Sigma-Aldrich, St. Louis, MO) and 0.1 µg/mL of 5-bromo-2′deoxycytidine (MP Biomedicals, Santa Ana, CA) were added to the culture media 18
hours prior to collection of the cells.
Fluorescent in situ hybridization (FISH)
FISH was performed as described previously (27). Metaphase chromosomes were
probed with a Cy3-(CCCTAA)3 (telomere) peptide nucleic acid (PNA) probe at 0.03
µg/mL and a FAM-CENPB (centromere) PNA probe at 0.03 µg/mL (PNA Bio, Thousand
Oaks, CA) and mounted using ProLong Gold (Life Technologies, Grand Island, NY) with
125 ng/mL DAPI (Sigma-Aldrich, St. Louis, MO).

Chromosome-orientation FISH (CO-FISH)
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CO-FISH was conducted as described previously (28) with modifications. Briefly,
metaphase chromosomes were rehydrated and treated with 100 µg/mL RNase for 10
minutes at 37 °C, rinsed, and re-fixed in 4% paraformaldehyde for 10 minutes at room
temperature. Chromosomes were UV sensitized in 0.5 µg/mL Hoechst 33258 (SigmaAldrich, St. Louis, MO) in 2x SSC for 15 minutes and exposed to 365 nm UV light for 60
minutes

using

a

UV

crosslinker

(Vilber-Lourmat,

Marne-la-Vallée,

France).

Chromosomes were then digested with 3 U/µL exonuclease III (Promega, Madison, WI)
for 15 minutes at room temperature, denatured in 70% formamide in 2x SSC at 72 °C
for 90 seconds, and immediately dehydrated in cold ethanol before hybridization.
Metaphase chromosomes were probed first with a FAM-(TTAGGG)3 (leading strand
telomere) PNA probe at 0.03 µg/mL, then probed with a Cy3-(CCCTAA)3 (lagging
strand telomere) PNA probe at 0.03 µg/mL (PNA Bio, Thousand Oaks, CA) and
mounted as described for FISH.

Immunofluorescence (IF) and IF–FISH
IF was carried out as described (29). For IF-FISH, following the completion of IF, the
cells were probed as described for chromosomes above using a Cy3-(CCCTAA)3
(telomere) PNA probe at 0.03 µg/mL (PNA Bio, Thousand Oaks, CA). Antibodies used
were: rabbit polyclonal anti-γH2AX (07-164, Millipore, Billerica, MA) and goat anti-rabbit
IgG–Alexa Fluor 488 (Life Technologies, Grand Island, NY).

Fluorescence imaging
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Chromosomes were imaged on a Nikon 90i epifluorescence microscope using a 100x
1.40 NA Plan Apo VC objective (Nikon Instruments, Melville, NY) with Cargille Type FF
or Cargille Type LDF immersion oil (Cargille-Sacher Laboratories, Cedar Grove, NJ) at
room temperature. Cells were imaged using a 40x 1.0 NA Plan Apo objective (Nikon
Instruments, Melville, NY) under the same conditions as those for chromosomes. Filter
cube sets used were: DAPI-1160B-000-ZERO, FITC-2024B-000-ZERO, and CY34040C-000-ZERO (Semrock, Inc., Rochester, NY).

Images were captured using a

CoolSnap HQ2 CCD camera (Photometrics, Tucson, AZ). Individual channel lookup
tables were auto-adjusted non-destructively and linearly, and images were deconvolved
with a blind algorithm using NISElements AR (Nikon Instruments, Melville, NY) prior to
quantification.

RNA preparation and northern hybridization
RNA was prepared using TRI Reagent (Life Technologies, Grand Island, NY). RNA was
serially diluted, denatured as previously described (30), and spotted onto a Hybond-XL
charged nylon membrane (GE Healthcare, Waukesha, WI) using a Bio-Dot
Microfiltration apparatus (Bio-Rad, Hercules, CA) according to the manufacturers’
instructions. Samples were also treated with ribonuclease A (Roche Applied Science,
Penzberg, Germany) and spotted to identify any DNA contamination in the RNA
preparation. Following UV crosslinking, the membrane was prehybridized in northern
hybridization buffer (15% formamide, 1% BSA, 100 mM sodium phosphate pH 7.7, 1
mM EDTA, 7% SDS) for one hour at 65 °C. A purified 1.6 kb fragment consisting
exclusively of vertebrate telomere repeats was random prime-labeled with [α-32P]dCTP
(3000 Ci/mmol) using the High Prime DNA Labeling Kit (Roche Applied Science,
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Penzberg, Germany) according to the manufacturer’s instructions to produce a
telomere-specific DNA probe. Similarly, a purified cDNA of the human 5S ribosomal
RNA was random prime-labeled to produce a 5S rRNA-specific DNA probe. Probes
were purified using Illustra ProbeQuant G-50 Micro Columns (GE Healthcare,
Waukesha, WI) and diluted to 1.2×106 dpm/mL in 10 mL of northern hybridization buffer.
Probes were hybridized to the membrane overnight at 65 °C, after which the membrane
was washed and imaged using either autoradiography or a storage phosphor screen
and imager. Quantitation was performed in Fiji by first background subtracting the
image and then computing the integrated density for each spot.

Quantitative reverse transcription PCR (qRT-PCR)
For qRT-PCR, cDNA was synthesized using Superscript III reverse transcriptase (Life
Technologies, Grand Island, NY) according to the manufacturer’s instructions. qRTPCR was conducted using TaqMan Gene Expression Assays (Life Technologies, Grand
Island, NY) according to the manufacturer protocol. Target genes used for verification of
α-amanitin efficacy were MYC (Hs00153408_m1) and SIAH1 (Hs02339360_m1).
Statistical analysis
Telomere fragility events were defined as chromatid arms with telomere FISH signal
observed as either multiple telomere signals or elongated smears as previously
described (7). Fragility was counted in metaphase chromosome spreads; for each
experimental condition, a minimum total of 600 chromosomes was counted. The
minimum sample size was chosen based on its ability to consistently detect aphidicolininduced and FEN1 depletion-induced telomere fragility. Chromosomes completely
lacking telomere FISH signal or exhibiting no strand specificity in CO-FISH (indicating
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the technical issue of incomplete brominated strand digestion) were excluded and not
quantified. Image groups were blinded prior to quantification. Two or more independent
biological replicates were carried out for each experiment.

Where data are shown as representative, the telomere fragility rate was computed for
each metaphase chromosome spread (% fragile telomeres), and each experiment was
statistically analyzed. Where data are shown as combined, telomere fragility rates were
computed for each metaphase chromosome spread, and a normalized value was
computed for each metaphase chromosome spread by dividing the raw value by the
mean of the control values. The mean of the normalized values from each sample in
two independent experiments was computed and graphed with error bars representing
the standard error of the mean. For statistical analysis, raw values were centered by
computing a t-statistic for each data point: the centered value for each chromosome
spread was calculated by dividing the residual of each raw value relative to the control
sample’s mean by the median absolute deviation of the control values. Centered values
from two independent experiments were then combined for statistical analysis. Data are
represented either by scatter plots with mean and standard error of the mean marked by
a line and error bars, or by a bar graph with bars indicating the mean and error bars
indicating standard error of the mean marked.

For IF, γH2AX foci were counted in each nucleus. A minimum of 30 nuclei was counted
for each condition in an experiment, and two independent biological replicates were
combined for data quantification. Data are represented by a box and whiskers plot with
the box marking 25th and 75th percentiles, line marking the median, whiskers marking
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the 5th and 95th percentiles, and dots marking data points outside the 5–95 percentile
range.

For all data, p-values were computed using a two-tailed Mann-Whitney U test with a
95% confidence interval in Prism 5 (GraphPad Software, La Jolla, CA). The MannWhitney U test was chosen because not all samples exhibited normal distributions. All
figures except the box and whiskers plot include standard error of the mean as an
indicator of variance, and in all cases the variance within samples was similar.

Results
FEN1 depletion and transcription inhibition induce replication stress and a DNA
damage response
Because telomeres are transcribed to produce telomeric repeat-containing RNA
(TERRA) (31,32), and because interference between replication and transcription is a
known cause of genomic instability (5,33,34), we turned our attention to the impact that
putative collisions between the replication and transcription machinery would have on
telomere stability. Unlike in Schizosaccharomyces pombe, where transcription of
telomeres and subtelomeres occurs using both strands as templates (35), mammalian
telomeres are transcribed exclusively using the C-rich leading strand as a template
(31,32); as such, co-directional collisions are the only type that can occur at the
telomere. In bacteria, co-directional collisions are resolved by a mechanism that leaves
behind an RNA:DNA hybrid/flap structure (20) which would need to be resolved in a
eukaryotic cell to avoid a DDR and genomic instability (21,22). FEN1 has been
previously shown to reduce telomere fragility (12), and the yeast FEN1 homolog
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Rad27p can hydrolyze RNA flaps (36). We hypothesized that co-directional collisions
are a molecular origin of telomere fragility, and that FEN1 can prevent post-collision
RNA:DNA hybrid/flap structures from accumulating, causing damage, and ultimately
leading to fragile telomere formation.

To address this hypothesis, we first examined whether increasing the rate of stochastic
collisions between the replisome and RNAP would increase replication stress and
trigger a DDR in the context of FEN1 depletion. We treated BJ fibroblasts with the RNA
polymerase II (Pol II) elongation inhibitor α-amanitin, a cyclic peptide toxin that reduces
the rate of Pol II transcription approximately 100-fold, allowing chain elongation to
continue without triggering transcript cleavage (37,38). We expected α-amanitin
treatment to increase the frequency of stochastic collisions between the replisome and
RNAP and thus increase replication stress and telomere fragility. Following transduction
with a validated shRNA targeting the 3′-untranslated region of the FEN1 mRNA
(shFEN1) (24) or a control hairpin (shCtrl), we treated BJ fibroblasts with either vehicle
or 10 µg/mL α-amanitin for 12 hours and collected both RNA and protein lysates from
the cells. qRT-PCR analysis confirmed the efficacy of α-amanitin treatment by
quantitation of two short-lived transcripts, c-Myc and SIAH1. α-amanitin-treated control
cells retained 2% and 6% of the c-Myc and SIAH1 mRNAs, respectively, compared to
the levels observed in vehicle-treated control cells. Similarly, in FEN1-depleted cells, αamanitin treatment resulted in 4% and 10% of the levels of c-Myc and SIAH1 mRNAs,
respectively, compared to vehicle-treated cells (Fig. 2.1A). Since transcription inhibition
by α-amanitin might reduce steady-state TERRA levels and produce telomere
phenotypes as a result of decreased TERRA, we carried out a northern blot analysis of
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total RNA to detect TERRA. Because TERRA are expressed at low levels in BJ
fibroblasts, we utilized a dot blot rather than a gel to maximize signal intensity and
hybridized the membrane to a telomere repeat-specific probe; treatment with
ribonuclease A was used to show the absence of contaminating DNA, and a 5S rRNAspecific probe was used as a loading control. Northern analysis of vehicle- and αamanitin-treated

cells

demonstrated

that

the

α-amanitin

treatment

conditions

subsequently used for western and metaphase analysis did not impact steady state
levels of TERRA in our system, demonstrating that the phenotypes resulting from the
treatment were not due to a loss of TERRA, which are known to impact telomere
stability (39,40) (Fig. 2.1B,C).

To determine if Pol II inhibition induces replication stress and a DDR in the context of
FEN1 depletion, we performed western blot analysis to examine phosphorylation of
Chk1 at S345 and phosphorylation of histone H2AX at S139 (γH2AX), classical markers
for the replication stress response and DDR, respectively. BJ fibroblasts transduced
with the control hairpin and treated with vehicle displayed neither Chk1 phosphorylation
nor H2AX phosphorylation (Fig. 2.2A). Treatment with α-amanitin induced a small but
detectable increase in Chk1 phosphorylation, but did not induce γH2AX, indicating that
α-amanitin treatment can induce limited replication stress, but is not sufficient to induce
a DDR (Fig. 2.2A). Similarly, BJ fibroblasts depleted of FEN1 and treated with vehicle
also displayed a small level of Chk1 phosphorylation and no detectable γH2AX (Fig.
2.2A). Strikingly, upon treatment with α-amanitin, FEN1-depleted cells showed a robust
phosphorylation of Chk1 and strong induction of γH2AX (Fig. 2.2A).
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We also used IF to examine the formation of γH2AX foci in asynchronous BJ fibroblasts,
and IF-FISH to assess the formation of telomere dysfunction-induced foci.
Quantification of γH2AX foci demonstrated that while FEN1 depletion induced foci
formation (2.14-fold in shFEN1+vehicle vs. shCtrl+vehicle, p < 0.0001), there was no
change in γH2AX foci upon treatment with α-amanitin (Fig. 2.2B,C). Furthermore, we
did not observe an increase in telomere dysfunction-induced foci in response to FEN1
depletion or α-amanitin treatment (data not shown). These results indicate first that the
amount of DNA damage induced in conditions that increase collision events causes a
response only robust enough to be detected by the more sensitive western analysis.
Second, they indicate that FEN1 depletion- and Pol II inhibition-induced replication
stress and DNA damage is not restricted to telomeres; rather, DNA damage likely
occurs throughout the genome wherever collisions occur. Thus, Pol II inhibition alone
induces mild replication stress, and the depletion of FEN1 combined with Pol II inhibition
results in a DDR that is not observed when FEN1 is depleted alone.

Inhibition of transcription exacerbates the telomere fragility observed upon FEN1
depletion
We next examined whether the replication stress and DDR phenotypes observed in
response to Pol II inhibition and FEN1 depletion manifest as telomere fragility. If failure
by FEN1 to resolve the structures induced by collision events between the replisome
and RNAP results in fragility, then we anticipated the rate of telomere fragility in αamanitin-treated and FEN1-depleted cells to mirror the replication stress phenotype. As
before, we transduced BJ fibroblasts with either shCtrl (control) or shFEN1 and treated
the cells with vehicle or α-amanitin for 12 hours prior to collecting metaphase
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chromosomes. Consistent with our model, cells expressing shCtrl exhibited an
increased rate of telomere fragility upon α-amanitin treatment (1.55-fold in shCtrl+αamanitin vs. shCtrl+vehicle, p = 0.0079) (Fig. 2.2D,E). When examining only the
vehicle-treated cells, we found that as previously demonstrated, FEN1 depletion causes
a significant increase in telomere fragility (2.15-fold in shFEN1+vehicle vs.
shCtrl+vehicle, p < 0.0001) (Fig. 2.2D,E). Strikingly, FEN1-depleted cells treated with αamanitin displayed a significant 2.76-fold increase in telomere fragility when compared
to control, vehicle-treated cells (shFEN1+α-amanitin vs. shCtrl+vehicle, p < 0.0001),
and a significant 1.28-fold increase compared to FEN1-depleted, vehicle-treated cells
(shFEN1+ α-amanitin vs. shFEN1+vehicle, p = 0.0017) (Fig. 2.2D,E). These fragility
data mirror the Chk1 phosphorylation phenotype and support a model in which αamanitin treatment increases co-directional replisome–RNAP collision events that result
in structures requiring FEN1 for resolution; without FEN1, the collision events generate
replication stress, a DDR, and fragile telomere formation. These experiments suggest
that FEN1’s role in limiting telomere fragility is dependent upon its ability to resolve
structures produced by telomere transcription during DNA replication.

Leading strand-specific telomere fragility is caused by RNA:DNA hybrids
Our data above suggest a role for telomere transcription in telomere fragility induced by
FEN1 depletion. Based on findings in prokaryotes, if co-directional collisions occur
between the replisome and an RNAP, a structure resembling an Okazaki fragment with
a segment of RNA:DNA hybrid would result (20); we postulate that if not resolved, this
structure could give rise to fragile telomeres. Indeed, post-collision structures resemble
R-loops, which are semi-stable displacement loops in which a nascent mRNA remains
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hybridized to its DNA template, while the coding strand DNA remains single-stranded,
resulting in replication stress and common fragile site expression (5). At common fragile
sites, the enzyme RNase H1 suppresses replication stress phenotypes induced by Rloop formation by hydrolyzing the RNA in RNA:DNA hybrids and thus resolving
displacement loops (5). We reasoned that since the post-co-directional collision
structure resembles an R-loop, RNA:DNA hybrids might be responsible for telomere
fragility, and thus ectopic expression of RNase H1 should resolve the structure and
telomere phenotype. Additionally, because our model predicts that the causative
structure for fragile telomere formation occurs after the replication fork has passed the
locus in question, we wondered if the telomere fragility observed upon FEN1 depletion
manifests only on the leading strand, where collisions could occur. This question was
especially prescient given that FEN1 is canonically a lagging strand replication protein,
and has a previously established role in limiting sister telomere loss at the lagging
strand (12).

Following lentiviral transduction with a control hairpin (shCtrl) or FEN1-depleting hairpin
(shFEN1), we transduced RPE1 cells with RNase H1 (Ad-RH1) (Fig. 2.3C) and
collected cells for protein analysis and metaphase chromosome preparation. To identify
if telomere fragility exhibited strand specificity, we used CO-FISH, a technique which
exploits the fact that the C-rich and G-rich strands of the mammalian telomere are
replicated exclusively by the leading and lagging strand machinery, respectively,
allowing the use of strand-specific probes to identify which machinery replicated a given
telomere on a metaphase chromosome (28). Strikingly, FEN1 depletion significantly
increased leading strand-specific telomere fragility (2.30-fold in shFEN1 vs. shCtrl, p =
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0.0021) (Fig. 2.3A,B) with no change observed on lagging strand-replicated telomeres
(1.26-fold in shFEN1 vs. shCtrl) (Fig. 2.3A,B). Additionally, ectopic expression of RNase
H1 rescued fragility on the leading strand-replicated telomere, returning fragility levels to
those observed in control cells (1.19-fold in shFEN1+Ad-RH1 vs. shCtrl) (Fig. 2.3A,B).
Given the specificity of RNase H1 for RNA:DNA hybrids, these data indicate that
RNA:DNA hybrids lead to telomere fragility and suggest that the hybrid/flap structures
that arise from co-directional collisions on the leading strand are responsible for the
telomere fragility observed upon FEN1 depletion. Furthermore, given that RPE1 cells
are telomerase-positive and telomerase expression rescues the sister telomere loss
observed upon FEN1 depletion, these data indicate that FEN1’s role in limiting telomere
fragility at the leading strand is distinct from its known role in limiting sister telomere loss
at the lagging strand (12,24).

α-amanitin is known to slow but not disengage the RNAP from the template strand
(37,38), and its use would be expected to increase replisome–RNAP collisions and
RNA:DNA hybrids. Thus, we next wanted to determine if the fragility we observed upon
α-amanitin treatment was also RNA:DNA hybrid-dependent. To address this question,
we transduced RPE1 cells with Ad-RH1 (Fig. 2.4C) and treated the transduced cells
with α-amanitin for 12 hours prior to metaphase collection. As before, α-amanitin
treatment induced an increase in telomere fragility (1.79-fold in α-amanitin vs. vehicle, p
= 0.0008) (Fig. 2.4A,B). As in the case of telomere fragility following FEN1 depletion,
ectopic RNase H1 expression protected α-amanitin-treated cells from telomere fragility,
resulting in levels similar to those observed in cells treated with vehicle (1.05-fold in AdRH1+α-amanitin vs. vehicle) (Fig. 2.4A,B). Because α-amanitin treatment exacerbates
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telomere fragility in the absence of FEN1 (Fig. 2.2D,E), the ability of RNase H1 to
rescue fragility in both α-amanitin-treated (Fig. 2.4A,B) and FEN1-depleted cells (Fig.
2.3A,B) suggests that FEN1’s role in limiting telomere fragility is to resolve RNA:DNA
hybrid/flap structures that are produced following replisome–RNAP collisions.

FEN1 flap endonuclease activity is required for limiting telomere fragility
Given the unprecedented finding that FEN1 limits leading strand-specific telomere
fragility, we sought to identify which of FEN1’s known functions were necessary for this
activity. FEN1 possesses three unique enzymatic activities: an endonuclease activity on
unannealed 5′ flaps consisting of either DNA or RNA, a weak exonuclease activity that
cleaves nicks, gaps, or recessed 5′ ends of double-stranded DNA, and a gap
endonuclease activity that cleaves double-stranded DNA at the 3′ end of a short singlestranded gap (41–43). FEN1 is also known to interact with PCNA via a PCNA
interacting peptide (PIP) box, directly pertaining to its role in DNA replication, and a
number of DNA repair proteins via its C-terminus, pertaining to its role in base excision
repair (44,45). We utilized a series of previously described FEN1 mutants that impact
FEN1’s different roles in replication (D181A, ΔP, ΔPΔC) versus repair (ΔC, D181A,
ΔPΔC, E160D) in genetic knockdown–rescue experiments (12,24) (Fig. 2.5A). To test
whether the reduction in telomere fragility mediated by FEN1 requires its DNA repair
functions, we used a lentiviral vector to express shCtrl (control) alone, shFEN1 alone, or
shFEN1 simultaneously with the wild type (WT), ΔC, or D181A allele of FEN1 (Fig.
2.5A); following transduction we prepared metaphase chromosomes. As before, FEN1
depletion induced leading strand-specific telomere fragility (2.05-fold in shFEN3 vs.
shLuc, p < 0.0001) (Fig. 2.5B,D). Expression of the WT allele of FEN1 rescued the
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leading strand-specific induction of telomere fragility upon endogenous FEN1
knockdown, indicating that the phenotype is specific to FEN1 knockdown (1.18-fold in
shFEN1+WT vs. shCtrl) (Fig. 2.5B,D). Unexpectedly, expression of the ΔC allele also
rescued FEN1 depletion-induced telomere fragility on the leading strand (1.02-fold in
shFEN1+ΔC vs. shCtrl) (Fig. 2.5B,D). In contrast to the WT and ΔC alleles, the D181A
nuclease-dead allele, which is deficient in all known nuclease activities (46,47), failed to
rescue the phenotype, instead resulting in an increase in leading strand-specific
telomere fragility comparable to the expression of shFEN1 alone (1.83-fold in
shFEN1+D181A vs. shCtrl, p < 0.0001) (Fig. 2.5B,D). Neither knockdown of FEN1 nor
expression of any of the mutant alleles of FEN1 altered the level of telomere fragility on
the lagging strand, confirming that FEN1 does not play a role in the phenotype on
lagging strand-replicated telomeres (Fig. 2.5B,D). These data indicate that FEN1’s flap
endonuclease activity is required to limit leading strand-specific telomere fragility, but its
interactions with several DNA repair proteins including WRN and BLM (deficient in the
ΔC allele), and thus its DNA repair activities, are dispensable for this role.
Consequently, FEN1’s ability to limit leading strand-specific telomere fragility is distinct
from its previously described role in telomere stability, which depends upon FEN1’s Cterminally mediated DNA repair activity to suppress sister telomere loss on the lagging
strand-replicated telomere (12,24).

Given that FEN1’s repair activity is dispensable for its ability to limit telomere fragility,
and telomere fragility is associated with replication stress, we next investigated whether
FEN1’s interaction with PCNA, and thus its replication activity, might be important in this
role. To test this possibility, BJ fibroblasts depleted of FEN1 were transduced with the
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WT, ΔP, ΔPΔC, or E160D cDNA of FEN1 (Fig. 2.5A). Analysis of telomere fragility on
metaphase chromosomes revealed that as before, expression of the WT allele rescued
the leading strand-specific induction of telomere fragility following FEN1 depletion (1.58fold in shFEN1 vs. shCtrl, p < 0.0001; 0.88-fold in shFEN1+WT vs. shCtrl) (Fig. 2.5C,D).
Surprisingly, expression of both the ΔP and E160D constructs also rescued the fragility
defect (0.77-fold in shFEN1+ΔP vs. shCtrl; 1.20-fold in BJ shFEN1+E160D vs. shCtrl)
(Fig. 2.5C,D). Only the ΔPΔC allele, a functionally null allele due to its lack of nuclear
localization, failed to rescue the leading strand telomere fragility observed upon FEN1
depletion, resulting in an increase similar to that observed upon FEN1 depletion alone
(1.61-fold in shFEN1+ΔPΔC vs. shCtrl, p < 0.0001) (Fig. 2.5C,D). As in the previous
experiment, none of the FEN1 alleles induced lagging strand-specific telomere fragility
(Fig. 2.5C,D). These data indicate that FEN1 requires neither its interaction with PCNA
(deficient in the ΔP allele), nor its gap endonuclease and exonuclease activity (deficient
in the E160D allele) to limit leading strand-specific fragility. In combination with the data
from expression of the ΔC and D181A mutants, our experiments identify FEN1 flap
endonuclease activity as necessary for its role in limiting telomere fragility. These data
are consistent with FEN1’s known activities, as it has previously been shown to cleave
flap structures with numerous modifications, including flaps composed of RNA
(36,43,48). As such, our data and the literature support a model in which FEN1’s flap
endonuclease activity could cleave the RNA:DNA hybrid/flap structures produced
following a replisome–RNAP collision event (Fig. 2.6).

Discussion
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The role of FEN1 described here provides new insights into the breadth of its functions
in maintaining genome stability. In addition to known roles in lagging strand DNA
replication, base excision repair, and lagging strand telomere stability, we illustrate for
the first time a role for FEN1 in leading strand replication. Furthermore, we have
identified transcription as an important contributor to telomere fragility, and we have
shown that FEN1 may resolve the RNA:DNA hybrid/flap structures resulting from
collisions between the transcription and replication machinery. The strand specificity of
telomere fragility observed in the absence of FEN1 shows that it has two independent
molecular roles for promoting telomere stability: (1) FEN1 limits sister telomere loss at
the lagging strand-replicated telomere by facilitating replication fork reinitiation (12), and
(2) FEN1 limits telomere fragility at the leading strand-replicated telomere by resolving
RNA:DNA hybrid/flap structures produced by co-directional replisome–RNAP collisions
(Fig. 2.6).

Though co-directional collisions between the replisome and RNAP are postulated to be
less deleterious to DNA replication than head-on collisions, they still necessitate
mechanisms to ensure replication fidelity. In bacteria, the primary replicative helicase,
DnaB, translocates along the lagging strand template as it unwinds DNA ahead of the
replication fork; as such, the helicase can move past an RNAP transcribing from the
leading strand, which would result in an inevitable collision between the two
polymerases (20). While accessory helicases such as Rep move along the leading
strand template, this activity alone cannot prevent co-directional collisions (20,49).
Bacteria thus can use a mechanism in which replication restarts on the leading strand
template following a co-directional collision using the 3¢ end of the nascent mRNA as a
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primer (20). Collisions between the replisome and RNAP also present a problem to the
eukaryotic cell, where highly-transcribed Pol II and Pol III genes are known to impede
replication fork progression (33,34). Extremely long genes that require more than a
single cell cycle to transcribe are also known to induce collision events; these collisions
induce common fragile site expression (5). Observations suggest that even though the
eukaryotic replicative helicase, a complex of Cdc45, Mcm2-7, and GINS (CMG),
translocates along the leading strand (50), its activity is insufficient to prevent collisions
from occurring. Indeed, CMG is unable to bypass both biotin-streptavidin and Qdot (20
nm) roadblocks on the leading strand (50). Even though the eukaryotic replicative
helicase translocates along the leading strand, our data suggest that it is unable to
bypass an RNAP and/or RNA:DNA hybrid on this strand. Together, these observations
suggest that eukaryotes require a similar mechanism to that used by bacteria for the
resolution of co-directional replisome–RNAP collisions on the leading strand.

Although FEN1 has no known existing roles in leading strand DNA replication, our
results provide an explanation consistent with the enzyme’s known substrates and
activity. The putative RNA:DNA hybrid/flap structure produced following a co-directional
replisome–RNAP collision is similar to the Okazaki fragment flaps FEN1 cleaves during
lagging strand replication—differing only in that the flap is composed entirely of
ribonucleotides. Thus, our model suggests that human FEN1 acts at the leading strand
because co-directional collisions at the telomere only happen on the leading strand
template. Because FEN1’s ability to limit telomere fragility does not require its Cterminal domain, which interacts with the shelterin protein TRF2 to recruit FEN1 to
telomeres during S and G2 phases of the cell cycle (24,51), it is unlikely that FEN1’s
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ability to process post-collision structures is limited to the telomere. However, in other
portions of the genome where replication begins from origins to either side of a
particular locus, transcription could be more coordinated with replication to prevent
head-on collisions from occurring. Wherever co-directional collisions occur, FEN1 is
likely able to process the structures produced.

Because the replication fork replicates the telomere in the centromere-to-telomere
direction only, and because mammalian telomeres are only transcribed from the C-rich
leading-strand template in the same direction (31,32), replisome–RNAP collisions at the
telomere can only occur co-directionally. Our work here, as well as the fact that TERRA
depletion induces telomere fragility (39), underscores the role of telomere transcription
in fragile telomere formation. Indeed, work in yeast has shown that RNA:DNA hybrids
produced by TERRA transcription promote recombination-mediated telomere elongation
(40). In ALT-positive cells, RNase H1 has recently been shown to regulate the levels of
RNA:DNA hybrids between TERRA and telomeric DNA (16). Like in yeast, TERRA
RNA:DNA hybrids are hypothesized to promote recombination between ALT telomeres.
In the absence of RNase H1, hybrids accumulate and promote excessive replication
stress that causes fragile telomere formation and telomere loss; conversely,
overexpression of RNase H1 reduces TERRA hybrids such that they cannot promote
recombination, leading to progressive telomere shortening (16). Strikingly, the telomere
loss that occurs following RNase H1 depletion in ALT cells is leading strand-specific
(16). This work, when combined with ours, strongly implicates transcription-associated
RNA:DNA hybrid formation at the telomere as a contributor to telomere fragility.
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Despite the recency of telomere fragility as a defined phenotype, it has been identified
in reports manipulating the expression of many proteins involved in DNA replication and
telomere stability. ATR deficiency or depletion, BRCA2 deletion, RAD51 depletion, and
RECQL1 depletion all induce elevated rates of telomere fragility (7–9,52,53). In addition,
CTC1 and STN1, both members of the mammalian CST complex, limit telomere fragility
(11). Like FEN1, these proteins participate in replication fork progression, replication
fork reinitiation, and telomere stability. To our knowledge, no report has identified any
perturbation that induces telomere fragility exclusive to the leading or lagging strand,
though RNase H1 overexpression has been shown to reduce telomere fragility at the
leading strand (16). Indeed, the lack of strand specificity in the telomere fragility
produced by TRF1 deletion (7), as well as the involvement of G-quadruplexes (which
form exclusively on the lagging strand) in RTEL1 deletion-induced telomere fragility
(10), suggests that there are multiple mechanisms leading to fragile telomere formation.
Our work underscores the complexity of DNA replication, and in placing the canonical
Okazaki fragment-processing protein FEN1 at the leading strand, reveals the first
molecular mechanism for fragile telomere formation on the leading strand.
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Figure 2.1. α-amanitin treatment abrogates expression of mRNAs with short half lives
but does not alter steady-state TERRA levels. (A) qPCR analysis of c-Myc and SIAH1
mRNA expression in cells expressing a control hairpin (shCtrl) or FEN1-depleted cells
(shFEN1), treated with either vehicle or α-amanitin (α-aman). mRNA levels in αamanitin-treated cells are shown as a fold change relative to the vehicle-treated cells.
Fold changes were calculated using the ΔΔCt method; fold changes from two biological
replicates were averaged to produce the graph. Error bars represent standard error of

77

the mean. (B) Northern dot blot to detect TERRA. RNA was isolated from cells
expressing a control hairpin (shCtrl) or FEN1-depleted cells (shFEN1) that were treated
with either vehicle or α-amanitin (α-aman). Serial dilutions of RNA were loaded onto a
membrane. Samples treated with RNase A to control for genomic DNA contamination
were also loaded (+RNase A). A telomere repeat DNA probe was hybridized to the
membrane (telomere probe) to detect TERRA; the membrane was stripped and reprobed with a 5S rRNA DNA probe (5S) as a loading control. The membrane was
visualized with autoradiography. (C) Quantification of TERRA in cells treated with αamanitin. The northern dot blot in (B) was imaged with a phosphor imager and analyzed
by densitometry using Fiji; TERRA levels in α-amanitin-treated cells are shown as a fold
change relative to vehicle-treated cells. Two independent experiments were averaged to
produce the graph; error bars represent standard error of the mean.
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Figure 2.2. FEN1 depletion and transcription inhibition induce replication stress, a DNA
damage response, and telomere fragility. (A) Western analysis of FEN1 expression,
Chk1 phosphorylation (pS345), and H2AX phosphorylation (γH2AX) in control (shCtrl)
or FEN1-depleted (shFEN1) cells treated with vehicle or α-amanitin (α-aman). β-catenin
is shown as a loading control. (B) Quantification of γH2AX foci per cell. Two
independent biological replicates were combined. The box marks the 25th to 75th
percentile with the median marked by a horizontal line, whiskers mark the 5th and 95th
percentiles, and dots represent values outside the 5–95 percentile range. p-values were
computed using a two-tailed Mann-Whitney U test (***, p < 0.001 relative to shCtrl). (C)
Representative immunofluorescence images stained with a γH2AX antibody (green)
and DAPI (blue) from BJ fibroblasts expressing a control hairpin (shCtrl) or depleted of
FEN1 (shFEN1). Cells were treated with vehicle or α-amanitin (α-aman) as indicated.
The scale bar (white) represents 25 µm. (D) Representative quantification of the rate of
telomere fragility. p-values were computed using a two-tailed Mann-Whitney U test (**, p
< 0.01; ***, p < 0.001). Error bars represent standard error of the mean. (E)
Representative metaphase chromosomes processed with FISH from BJ fibroblasts
expressing a control hairpin (shCtrl) or depleted of FEN1 (shFEN1). Cells were treated
with vehicle or α-amanitin (α-aman) as indicated. Centromeres are green and telomeres
are red. Arrowheads mark fragile telomeres in the magnified images.
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Figure 2.3. RNA:DNA hybrids are responsible for FEN1 depletion-induced leading
strand-specific telomere fragility. (A) Representative metaphase chromosomes
processed with CO-FISH from RPE1 cells expressing a control hairpin (shCtrl) or
depleted of FEN1 (shFEN1), with or without ectopically expressed RNase H1 (Ad-RH1).
Leading strand-replicated telomeres are green and lagging strand-replicated telomeres
are red. Arrowheads mark fragile telomeres in the magnified images. (B) Representative
quantification of the rate of strand-specific telomere fragility, with leading strand-specific
telomere fragility shown in green and lagging strand-specific telomere fragility shown in
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red. p-values were computed using a two-tailed Mann-Whitney U test (*, p < 0.05; **, p
< 0.01). Error bars represent standard error of the mean. (C) Western analysis of FEN1
and RNase H1 expression in control (shCtrl) or FEN1-depleted (shFEN1) cells, with or
without ectopically expressed RNase H1 (Ad-RH1). Two exposures of the same RNase
H1 blot are shown. α-tubulin is shown as a loading control.
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Figure 2.4. RNA:DNA hybrids are responsible for α-amanitin-induced telomere fragility.
(A) Representative metaphase chromosomes processed with FISH from RPE1 cells
with or without ectopically expressed RNase H1 (Ad-RH1) and treated with either
vehicle or α-amanitin (α-aman). Centromeres are green and telomeres are red.
Arrowheads mark fragile telomeres in the magnified images. (B) Representative
quantification of the rate of telomere fragility. p-values were computed using a two-tailed
Mann-Whitney U test (***, p < 0.001). Error bars represent standard error of the mean.
(C) Western analysis of RNase H1 expression in cells with or without ectopically
expressed RNase H1 (Ad-RH1) treated with vehicle or α-amanitin (α-aman). Two
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exposures of the same RNase H1 blot are shown. α-tubulin is shown as a loading
control.
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Figure 2.5. FEN1 flap endonuclease activity is required to limit leading strand-specific
telomere fragility. (A) Schematic showing FEN1 alleles used in this study. Features
indicated include a PIP box (PIP), nuclear localization signal (NLS), C-terminal region
(C), and point mutations. The replication competency, repair competency, and ability to
rescue telomere fragility (this study) of each allele are shown to the right. (B)
Representative metaphase chromosomes processed with CO-FISH from BJL fibroblasts
expressing a control hairpin (shCtrl) or depleted of FEN1 (shFEN1). Leading strandreplicated telomeres are green and lagging strand-replicated telomeres are red. FEN1
alleles were ectopically expressed where indicated. Arrowheads mark fragile telomeres
in the magnified images. (C) Representative metaphase chromosomes processed with
CO-FISH from BJ fibroblasts expressing a control hairpin (shCtrl) or depleted of FEN1
(shFEN1). Leading strand-replicated telomeres are green and lagging strand-replicated
telomeres are red. FEN1 alleles were ectopically expressed where indicated.
Arrowheads mark fragile telomeres in the magnified images. (D) Quantification of
strand-specific telomere fragility per chromosome, with leading strand-specific telomere
fragility shown in green and lagging strand-specific telomere fragility shown in red. Two
independent biological replicates were analyzed, normalized with shCtrl set to 1 for
each mutant group, and combined. p-values were computed using a two-tailed MannWhitney U test (***, p < 0.001 relative to shCtrl). Error bars represent standard error of
the mean.
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Figure 2.6. A model of FEN1’s role following co-directional replisome–RNAP collisions.
(A) RNA Pol II (RNAP) transcribes TERRA from the C-rich leading strand. The
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replisome approaches the transcription complex and a co-directional collision occurs.
Pol II dissociates from the nascent TERRA. (B) The replisome moves to the 3¢ end of
the TERRA, leaving a 5¢ RNA flap and RNA:DNA hybrid. (C) The replisome resumes
replication of the leading strand using the 3¢ end of the nascent TERRA as a primer. (D)
FEN1 cleaves the 5¢ RNA flap left behind by the collision. (E) FEN1’s cleavage leaves
behind a gap and a stretch of RNA:DNA hybrid that can be repaired. (F) In the absence
of FEN1, RNA:DNA hybrid/flap structures accumulate and lead to telomere fragility.
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Introduction
High-fidelity DNA replication is paramount to the maintenance of genome stability.
Therefore, cells have evolved various redundant mechanisms to resolve genotoxic
challenges including the presence topological structures. If not resolved, these
structures can impede replication fork progression, leading to the stalling and eventual
collapse of replication forks (1). One such structure is the RNA:DNA hybrid, commonly
referred to as an R-loop. Mapping studies have revealed that RNA:DNA hybrid
structures are present throughout the genome more frequently than previously
appreciated (2, 3). One source of R-loops is transcription during which nascent RNA
emanating from RNA polymerase II hybridizes with its template DNA (4). While these
topological structures play a vital role in a number of key processes including class
switch recombination (CSR) of immunoglobulin genes and transcription termination,
their persistence or unscheduled formation and stabilization pose a significant challenge
to genome integrity (5, 6). Because DNA replication and transcription occur
simultaneously at many regions of genome, hybrids can form in front of the replication
machinery and affect its progression. Indeed, these R-loops can lead to increased DNA
mutations, unwanted recombination and gross chromosomal aberrations (7). Thus it is
not surprising that a number of proteins inhibit the formation of these structures or
resolve them once they have formed (4). Topoisomerase I and mRNA export and
splicing factors, for example, play an active role in preventing R-loop formation (4, 8).
On the other hand, the helicases Senataxin (SETX) and Aquarius (AQR), are tasked
with resolving these structures to promote transcriptional termination and maintain
genome stability respectively (6, 9). In addition, DNA damage response factors such as
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breast cancer susceptibility factors (BRCA1 and BRCA2) are also implicated in
preventing R-loop accumulation and the ensuing DNA damage (10, 11).

Ribonuclease H1 (RNH1) is a specialized enzyme that can specifically resolve long
RNA:DNA hybrids. A closely related protein complex, ribonuclease H2 (RNH2) is adept
at removing single misincorporated ribonucleotides from DNA and is critical for ongoing
genomic stability (12). In yeast, RNH1 and RNH2 function redundantly to facilitate
efficient double strand break repair during homologous recombination by assisting in the
unwinding of DNA strands and RPA binding (13). Ectopic expression of RNH1 in yeast
is sufficient to minimize transcription-dependent hyper-recombination, pausing of the
replication fork, and HU sensitivity (14, 15, 16). In mammalian cells, RNH1 has an
established role in mitochondrial DNA replication, and its deletion is embryonically
lethal, demonstrating that RNH2 cannot compensate in this setting (17, 18, 19, 20).
RNH1 localizes to the mammalian nucleus (21) and ectopic RNH1 expression is
routinely exploited in mammalian cells to resolve RNA:DNA hybrids. Recently RNH1
was shown to prevent unwanted recombination events at telomere by resolving
telomeric RNA:DNA hybrids in cells that utilize the ALT mechanism of telomere
maintenance (22). Another recent study identified a link between DNA damage and the
accumulation of RNA:DNA hybrids at the telomere (23). However, whether RNH1 plays
a role in nuclear DNA replication outside of telomeres remains to be explored.

Given the role of RNA:DNA hybrids in replication impairment and the ability of RNH1 to
resolve such hybrids, we sought to determine if RNH1 impacts genomic integrity in the
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mammalian nucleus and if so how. We depleted RNH1 from human cell lines and found
that RNH1 depletion resulted in increased RNA:DNA hybrids, DNA damage response,
and slowing of DNA replication forks. Importantly, these phenotypes were dependent
upon RNH1 nuclease activity, suggesting that the hybrids were responsible for these
phenotypes. Our studies uncover a novel role of RNH1 in the mammalian nucleus and
extend its important function in nuclear DNA replication.

Experimental Procedures
Cell culture
Cells were cultured at 37 C in 5% carbon dioxide and atmospheric oxygen, as
previously reported (24). 293T cells were obtained from Dr. Robert Weinberg
(Massachusetts Institute of Technology) and cultured in high-glucose Dulbecco’s
modified Eagle’s medium (DMEM) containing 10% heat inactivated fetal bovine serum
(FBS) and 1% penicillin/ streptomycin (P/S) (Sigma-Aldrich, St. Louis, MO). RPE1
cells were obtained from ATCC and cultured in DMEM: Nutrient Mixture F-12
(DMEM/F12) containing 7.5% FBS and 1% P/S.

siRNA transfection
siRNA transfection was performed using Invitrogen’s Lipofectamine RNAiMAX Reagent
(Thermo Fisher Scientific) according to the manufacturer’s protocol. siRNAs used were
control (siCtrl- Cat #4390843) or RNH1-directed (siRNH1- Cat #4390824, ID s48356)
from Life Technologies or that directed to the 3’ UTR of RNH1 (siRNH1- hs.Ri.
RNASEH1.13.1) from Integrated DNA Technologies.
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Virus production, infections, and stable cell lines
Lentiviral production and transductions were carried out as previously reported (25).
Briefly, 293T cells were transduced with an 8:1 ratio of pHR -CMV-8.2 R packaging
plasmid and pCMV-VSV-G and a pLKO.1-puro plasmid carrying an shRNA using
TransIT-LT1 (Mirus Bio, Madison, WI). Supernatant-containing virus was collected 48
hours post-transfection and filtered through a 0.45- μm PVDF membrane. RPE1 cells
were infected for 4 hours each on 2 consecutive days in the presence of 8 μg/ml
protamine sulfate (Sigma). Following infection, transduced cells were selected with 15
μg/ml puromycin sulfate. Stable RPE1 cell lines were prepared by using either a GFP
tagged D145N RNH1 construct (a generous gift of Dr. Marteijn) (26) or its wildtype
version (modified from D145N construct using site directed mutagenesis, Agilent
Technologies).

Western Blot Analysis
Western blot analysis was carried out as previously described with modifications (27).
Briefly, cells were washed with PBS and lysed in radio-immunoprecipitation assay buffer
(150 mM NaCl, 50 mM 1 M Tris-HCl, pH 8.0, 1.0% NP-40, 0.5% sodium deoxycholate,
and 0.1% SDS) supplemented with 1 mM sodium orthovanadate, 1 mM sodium fluoride,
1 mM microcystin-LR, 2 mM phenylmethylsulfonyl fluoride, protease inhibitor mixture
(Sigma), and phosphatase inhibitor mixture set I (EMD Millipore, Billerica, MA).
Following sonication and centrifugation, supernatant lysate was quantified using the
protein assay (Bio-Rad). Lysates were subjected to a SDS-PAGE and transferred to
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PVDF membranes for blotting. The following antibodies were used: mouse monoclonal
anti RNase H1 (H00246243-M01, Novus Biologicals, Littleton, CO); rat monoclonal antitubulin (NB600-506, Novus Biologicals, Littleton, CO); mouse monoclonal anti- phospho
(Ser 139) H2AX (05-636, Millipore, CA).

Metaphase Chromosome Preparation
Metaphase chromosomes were prepared as described previously (28). Briefly, cultured
RPE1 cells were treated with 0.5 μg/ml colcemid (Sigma) for 6 hours. Arrested
metaphase cells were collected by mitotic shake-off, treated with 75 mM potassium
chloride, and fixed in 3:1 solution of methanol and acetic acid. Chromosomes were
spread by dropping onto glass slides. For analysis via COFISH, 0.3 μg/ml 5-bromo-2’deoxyuridine (Sigma) and 0.1 μg/ml 5-bromo-2’-deoxycytidine (MP Biomedicals, Santa
Ana, CA) were added to the cultured media 18 hours prior to collection of the cells.

Chromosome Orientation - FISH (CO-FISH)
CO-FISH was performed as described previously with modifications (29). Briefly, spread
metaphase chromosomes were aged at 65 °C for 18 hours. Aged chromosomes were
rehydrated in PBS, treated with 100 μg/ml RNase at 37 °C for 10 min and re-fixed in 4%
paraformaldehyde at room temperature (RT) for 10 min. Fixed chromosomes were UVsensitized in 0.5 μg/ml Hoechst 33258 (Sigma) in 2X SSC at RT for 15 min and
exposed to 365 nm UV light for 1 hour using a UV cross-linker (Vilber-Lourmat, Marnela- Vallée, France). Exposed chromosomes were digested with 3 units/μl Exonuclease
III (Promega, Madison, WI) at RT for 15 min, denatured in 70% formamide in 2X SSC,
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and dehydrated in cold ethanol before hybridization. Chromosomes were hybridized first
using 0.03 μg/ml (PNA Bio, Thousand Oaks, CA) of a leading strand telomere PNA
probe (FAM-(TTAGGG)3) followed by 0.03 ug/ml of a lagging strand PNA probe (Cy3(CCCTAA)3). Hybridized chromosomes were mounted using ProLong Gold (Life
Technologies, Inc.) with 125 ng/ml DAPI.

Microfluidic- Assisted Replication Track Analysis (maRTA)
maRTA was conducted as described previously (30, 31). Briefly, asynchronous RPE1
cells were labelled for 30 min each with 50 μM CldU and 50 μM IdU with two PBS
washes in between. Labelled cells were collected and embedded in agarose plugs for
lysis and DNA extraction. DNA was subsequently stretched, denatured and subjected to
immunostaining. Antibodies used were rat anti-CldU/BrdU (Abcam, ab6326), mouse anti
IdU/BrdU (BD Biosciences, 347580), goat anti-rat Alexa 594 (Invitrogen, A11007), and
goat anti-mouse Alexa 488 (Invitrogen, A11001).

Fluorescence Imaging
Metaphase chromosomes from COFISH and labelled DNA tracks from maRTA were
imaged on a Nikon 90i epifluorescence microscope using a 100 X 1.40 NA Plan Apo VC
objective (Nikon Instruments, Meliville, NY) with Cargille Type LDF immersion oil
*Cargille Sacher Laboratories, Cedar Grove, NJ). Images were captured using a
CoolSnap HQ2 CCD camera (Photometrics, Tucson, AZ), deconvulated with a blind
algorithm using NISElements AR (Nikon Instruments) prior to quantification. RPE1 cells
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stably expressing GFP tagged WT and D145N RNH1 were visualized and captured
without any staining.

DNA immunoprecipitation (DIP)
DIP was performed as described previously with modifications (6). Briefly, 293T cells
were pelleted and resuspended in DIP lysis buffer (0.5% NP40, 85 mM potassium
chloride, and 5 mM PIPES). Following centrifugation, pelleted nuclei were lysed in DIP
nuclear lysis buffer (1% sodium dodecyl sulfate, 25 mM tris-HCl pH 8, and 5 mM
EDTA), sheared and digested with two sequential rounds of 100 μg proteinase K for 1.5
hours each at 55 °C. DNA was phenol:chloform extracted and ethanol-precipitated (32)
at which point one half was subjected to an overnight digestion with recombinant
ribonuclease H (Roche Applied Science, Penzberg, Germany). Samples were then
diluted in DIP dilution buffer (1.1% Triton X-100, 0.01% sodium dodecyl sulfate, 1.2 mM
EDTA, 16.7 mM tris-HCl pH 8, and 166.5 mM sodium chloride) and sonicated to
generate about 200 bp long DNA fragments. Resulting DNA was quantified using the
PicoGreen assay following the manufacturer’s protocol (Life Technologies, Grand
Island, NY). 10 μg of DNA was immunoprecipitated overnight with 10 μg of S9.6
antibody or mouse IgG. Antibody- DNA complexes were captured by using Protein A
magnetic beads (Life Technologies, Grand Island, NY) after equilibration in DIP dilution
buffer. After extensive washing, antibody- DNA complexes were eluted from the beads
and treated with proteinase K followed by recovery using PCR cleanup columns
(Qiagen, Venlo, Netherlands).
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S9.6 Immunofluorescence (S9.6 IF)
S9.6 IF was performed as previously described (9). Briefly, RPE1 cells transfected with
siCtrl or siRNH1 were fixed with ice-cold methanol for 5 min at -20°C. Fixed cells were
blocked in 2% BSA/PBS for an hour at room temperature followed by incubation with
the S9.6 primary antibody (1:200 dilution, 1 ug/mL) and goat anti-mouse AlexaFluro-594
conjugated secondary antibody (1:1000, Invitrogen) for 1 hour each at room
temperature. Finally, cells were washed in 0.5 μg/ml Hoechst 33258 PBS to label the
nuclei and mounted using ProLong Gold. Images were taken at 40X using a Nikon 90i
epifluorescence microscope as previously described. Only the nuclear staining of S9.6
signal was considered and analyzed using ImageJ 1.50i.

Genomic Quantitative PCR (qPCR)
Genomic qPCR was performed using Power SYBR Green Master Mix (Life
Technologies, Grand Island, NY) following the manufacturer’s protocol. 5’ region of the
Beta-actin pause element (5’ pause site), known to form RNA:DNA hybrids, was
amplified to assess hybrid formation. Reaction conditions were as described in
manufucturer’s instructions with 58.7 °C as the annealing temperature. Primers used
were: 5′-TTACCC AGA GTG CAG GTG TG-3′ (Forward) and 5′-CCC CAA TAA GCA
GGA ACA GA-3’ (Reverse).

Quantitative Reverse Transcription - PCR (qRT-PCR)
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qRT-PCR was performed as described previously (24). Target genes used were RNH1
(Hs00268000_m1, Life Technologies, Inc.) and GAPDH (Hs. PT.39a.22214836,
Integrated DNA Technologies).

RESULTS
RNH1 contributes to genome stability and preserves telomere integrity
While RNH2 has well ascribed functions in the mammalian nucleus, RNH1’s role has
remained more obscure. Because R-loops form throughout the genome and RNH1 can
resolve R-loops that would pose barriers to the replication machinery, we hypothesized
that RNH1 might play an important role in the nucleus and that its loss might perturb
replication fork progression and thus elicit a DNA damage response (4). To test this
hypothesis, we depleted RNH1 from normal, checkpoint-competent RPE1 cells and
measured the levels of histone H2AX phosphorylation at S139 (ΥH2AX), a canonical
marker of the DNA damage response (33) in control versus RNH1-depleted cells.
Following RNH1 depletion, we observed increased levels of ΥH2AX, demonstrating that
RNH1 depletion induces a DNA damage response (Fig 3.1A,B). These data suggest
that RNH1 plays an important role in preserving genome stability.

To further interrogate RNH1’s function, we first focused our attention to telomeres,
chromosomal ends that contain RNA:DNA hybrids (34). Recent work demonstrates that
in cells utilizing the alternative lengthening of telomeres (ALT) mechanism, which
maintains telomere length independent of telomerase—RNH1 associates with
telomeres and regulates the levels of telomeric RNA:DNA hybrids to prevent telomere
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loss (22). In these cells, depletion of RNH1 led to hybrid accumulation and abrupt
telomere excision. A second study suggested that RNH1 plays an important role in
resolving RNA:DNA hybrids at the telomere (23). Because the leading strand replicated
telomere is transcribed, RNA:DNA hybrids would be expected to form on the leading
strand. Thus, we examined the integrity of the leading strand telomere by performing
chromosomal orientation fluorescent in situ hybridization (CO-FISH), which allows one
to interrogate the leading versus lagging strand replicated telomere. Surprisingly, COFISH analysis revealed no differences in the leading versus lagging strand telomere in
control versus shRNH1 cells (data not shown). However, in the RNH1-depleted cells,
we observed a significant increase in telomere free ends (TFE), in which both leading
and lagging strand telomeres were lost, a phenotype suggestive of DNA replication
defects (35) (Fig. 3.1C,D). These data suggest that RNH1 assists the replication
machinery by resolving RNA:DNA hybrids that could present a topological barrier to
replication fork progression.

Nuclear RNA:DNA hybrid levels increase upon RNH1 depletion
To demonstrate that RNA:DNA hybrids were responsible for DNA damage and telomere
loss phenotype upon RNH1 loss, we next measured those hybrid levels in the nucleus.
We treated 293T cells with control (siCtrl) or RNH1 directed (siRNH1) siRNAs and
collected cells 48 hours later. Transfection with siRNH1 led to a significant (2.5 fold)
reduction in RNH1 mRNA levels (Fig. 3.2A) and (3.5 fold) protein levels (Fig. 3.2B)
compared to levels present in siCtrl cells. To measure the amount of RNA:DNA hybrids
in control versus RNH1-depleted cells, we next extracted nuclear DNA lysate and
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subjected it to DNA:RNA immunoprecipitation (DIP) using the well characterized
RNA:DNA hybrid antibody, S9.6 (36). We conducted a genomic quantitative PCR on a
well-characterized hybrid forming 5’ pause site of beta-actin gene as a readout of hybrid
signals. As a control for specificity, we also pretreated lysates with recombinant
RNaseH enzyme in vitro to degrade existing RNA:DNA hybrids in both control and
depleted cells. As expected, pretreatment with an in vitro RNaseH enzyme led to a 1.8
fold reduction of RNA:DNA hybrids in control and a 3.5 fold in RNH1-depleted cells,
confirming the specificity of the S9.6 antibody. Additionally, immunoprecipitation with an
IgG control antibody failed to precipitate RNA:DNA hybrids, indicating that the signals
we measured were bona fide RNA:DNA hybrids. Analysis of immunoprecipitations from
RNH1-depleted cells revealed a significant two-fold increase in the nuclear RNA:DNA
hybrids compared to those in control cells (Fig. 3.2C). To further corroborate these
findings, we also utilized the S9.6 antibody and carried out immunofluorescence on
RPE1 cells. As expected, RNH1-depleted cells showed increased levels of RNA:DNA
hybrids as represented by elevated S9.6 signal in the nucleus compared to that in the
control cells (Fig. 3.2D,E). Together, these data demonstrate that RNH1 depletion can
lead to a significant increase in RNA:DNA hybrids and that this increase correlates with
increased DNA damage and telomere loss.

RNH1 depletion results in replication fork slowing and increased termination and
stalling
Given the increased RNA:DNA hybrids and DNA damage and loss of both telomeric
ends, indicative of a replication defect following RNH1 depletion, we hypothesized that
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RNA:DNA hybrids pose barriers to DNA replication forks. This hypothesis was
supported by previous studies showing that the removal of RNA:DNA hybrids by
ectopically expressed RNH1 can directly affect replication fork movement in yeast (37).
To test this hypothesis, we used microfluidic-assisted replication track analysis
(maRTA) to directly measure replication fork progression in RPE1 cells depleted of
RNH1 (30, 38). RPE1 cells were transduced with siRNAs and cells were collected for
western blot analysis 48 hours later. As expected, RNH1 depletion resulted in significant
DNA damage as evidenced by increased ΥH2AX (Fig. 3.3A). In parallel, we carried out
maRTA by plating RNH1-depleted or control cells and labeling them with the nucleotide
analogs, CldU (red) and IdU (green), sequentially for 30 minutes each, to allow us to
follow replication fork movement (Fig. 3.3B). To restrict our analysis to progressing
replication forks, we measured IdU tracks that were directly preceded by a CldU track
(Fig. 3.3B). Measuring the lengths of these IdU tracks, we found that RNH1 depleted
cells had an average IdU track length of 9.3 (+/- 0.3) μm while that in the control cells
was 14.5 (+/-0.4) μm, indicating that the replication forks moved significantly slower in
RNH1 depleted cells compared to control cells (Fig. 3.3C). Given the increase in
RNA:DNA hybrids associated with RNH1 loss, these data suggest that RNH1 facilitates
efficient DNA replication by clearing RNA:DNA hybrids that would otherwise impede
replication fork progression during S phase.

To understand how the loss of RNH1 perturbed replication dynamics, we next asked
whether other replication parameters including termination, stalling, and origin firing
were affected upon RNH1 depletion. Premature termination and stalling events
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correspond to CIdU (red)-only tracks (Fig. 3.3B). RNH1-depleted cells showed a
significant 1.4 fold increase in termination and/or stalling events compared to control
cells (Fig. 3.3D). Next, we analyzed the impact of RNH1 depletion on origin firing to
address a possibility that slower fork progression triggers the S phase checkpoint and
increases the frequency of origin firing as previously reported (39). To measure origin
firing, the incidence of tracks with either green-only (IdU) color or red flanked by green
on both sides was analyzed (Fig. 3.3B). However, no significant differences in origin
firing were observed between RNH1-depleted and control cells (Fig. 3.3E). Collectively,
these results indicate that RNH1 plays an important role in assisting fork movement
during DNA replication. We suggest that RNH1 does this by resolving RNA:DNA hybrids
that pose barriers to a progressing replication fork. Furthermore, our data provide the
first evidence of RNH1’s role in global DNA replication in the mammalian nucleus.

Nuclease activity of RNH1 is required for efficient replication fork movement
To further characterize RNH1’s role in DNA replication, we tested whether the nuclease
function of RNH1 was required for this activity. To do this, we created a series of RPE1
cell lines ectopically expressing either a GFP-tagged wild type (WT) or a well
characterized GFP-tagged nuclease-dead (D145N) form of RNH1 (26, 40). To establish
a direct role in the nucleus, these RNH1 constructs lacked the mitochondrial targeting
sequence present in the endogenous gene, thereby restricting their expression to the
nucleus. We confirmed the nuclear localization of ectopically expressed proteins by
visualizing GFP expression only in the nucleus (Fig. 3.4A). These stable RPE1 cells
were transfected with an siRNH1 directed towards the 3’ untranslated region (3’UTR)
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that did not target the ectopically expressed protein. We observed that RNH1 depletion
using a 3’ UTR siRNA was comparable to that of a previously used coding sequence
(CDS) targeting siRNA (Fig. 3.4B). We also observed robust expression of our
ectopically tagged RNH1 proteins and significant depletion of endogenous RNH1 levels
(Fig. 4B). Next, using maRTA, we again measured replication fork movement and found
that ectopic expression of WT RNH1 restored fork movement to the levels observed in
siCtrl cells (Fig. 3.4C). Indeed, while RNH1 depleted forks moved an IdU length of 8 μm,
ectopic expression of WT RNH1 increased this to 12 μm, levels we observed in siCtrl
cells. In contrast, ectopic expression of the catalytically-dead D145N allele of RNH1
failed to rescue the replication fork movement defect (fork movement was 7.9 μm,
nearly identical to that observed in RNH1 depleted cells). Together, these findings
demonstrated that the nuclease activity of RNH1 is required for the unperturbed
movement of replication forks in mammalian cells. Similarly, we also measured fork
termination and stalling events upon ectopic expression of WT and D145N alleles in
RNH1 depleted cells. As expected, both events were reversed by ectopic expression of
WT RNH1 but not the nuclease dead allele, thereby reiterating the importance of the
nuclease function of RNH1 in the fidelity of replication fork progression (Fig. 3.4D).
Neither WT nor D145N alleles of RNH1 affected the levels of origin firing in RNH1
depleted cells (Fig. 3.4E). These data suggest that the nuclease activity of RNH1 is
required for resolution of RNA:DNA hybrids and therefore efficient movement of
replication forks during nuclear DNA replication.
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Discussion
Our study establishes a role for RNH1 in genomic DNA replication. Indeed, we illustrate
for the first time that RNH1 nuclease activity is required for efficient fork movement
during nuclear DNA replication. Furthermore, we have established a correlation
between the accumulation of RNA:DNA hybrids and replication defects observed upon
RNH1 depletion. Taken together, we propose a model wherein RNH1 resolves
RNA:DNA hybrids to assist the replication machinery in its uninterrupted movement
during DNA replication.

The unscheduled formation and stabilization of RNA:DNA hybrids have been postulated
to be detrimental to the replication machinery.

The importance of resolving these

structures is probably best underscored by the multitude of proteins that act on
RNA:DNA structures. Indeed, helicases such as SETX, AQR, and DHX9 in mammalian
cells and Sen1 and PIF1 in yeast have all been shown to resolve RNA:DNA hybrids (9,
41, 42, 43). Here we add RNH1 to a growing list of proteins and show that endogenous
RNH1 is required to similarly remove RNA:DNA hybrids and if these hybrids are not
removed, replication is significantly impacted. Further our work demonstrates that these
other proteins are unable to compensate for loss of RNH1 in replication fork
progression. However, how RNH1 is regulated in the nucleus and how its activity is
coordinated with the replication machinery remains unclear.

A recent study from

Nguyen et al., elegantly demonstrated that RPA can interact with RNH1 and stimulate
it’s activity raising the possibility that RNH1 is tightly regulated by the DNA replication
and repair machinery (44).
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Given that RNH1 loss elicits replication defects such as fork slowing and termination
and fork stalling, it will be critical to determine how this impacts checkpoint activation
and cell cycle progression. Furthermore, understanding the fate of accumulated
RNA:DNA hybrids upon RNH1 depletion is another interesting avenue worth pursuing.
As previously noted, RNA:DNA hybrids arising from different sources can be processed
via separate mechanisms (9). For example, those involved in CSR are not processed
via nucleotide excision repair (NER) whereas those arising from loss of some RNA
processing factors or CPT treatment are processed by NER. It is also worth evaluating if
redundant nucleases and helicases including RNaseH2, SETX, and AQR could rescue
effects of RNH1 loss.

The study of R-loops and their resolution have sparked more attention in recent years
due to the fact that R-loops are associated with a number of diseases including cancers
and several neurodegenerative disorders (45). This underscores a need for
understanding these structures, their origins, stabilization and resolution along with their
impact on cellular processes. By revealing RNH1’s function in R-loop resolution in the
nucleus, our study adds to the diversity of mechanisms targeting such structures.
Furthermore, our study identifies a previously unknown function of RNH1 in nuclear
DNA replication. Together, our work broadens the understanding of RNA:DNA
structures and places RNH1 as a novel mechanism to resolve those structures and
assist in nuclear DNA replication.
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Figure 3.1. RNH1 contributes to genome stability and preserves telomere integrity
A. Western analysis of RNH1 expression (RNH1) and H2AX phosphorylation (γ H2AX)
in control (shCtrl) and RNH1 depleted RPE1 cells (shRNH1). Bleo treated cells (Bleo) is
a positive control for γ H2AX. α Tubulin is shown as a loading control. Molecular weight
in kilodaltons is marked to the right for reference. B. Quantification of γ H2AX intensity
in shCtrl and shRNH1 cells from western blot in A. C. Representative metaphase
chromosomes processed with CO-FISH from shCtrl or shRNH1 RPE1 cells. Leading
strand-replicated telomeres are green, and lagging strand-replicated telomeres are red.
Regions marked by white asterisks are magnified; white arrowheads indicate telomere
free ends (TFE) in magnified images. D. Representative quantification of telomere loss
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in shCtrl and shRNH1 RPE1 cells. A minimum of 700 metaphase chromosomes were
analyzed. p values were computed using a two-tailed Student’s t test (*, p<0.05). Error
bars represent standard error of the mean.
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Figure 3.2. Nuclear RNA:DNA hybrid levels increase upon RNH1 depletion
A. qRT-PCR analysis of RNH1 mRNA in 293 T cells transfected with a control siRNA
(siCtrl) or RNH1-targeted siRNA (siRNH1). Expression levels were calculated using the
Ct method and normalized relative to GAPDH expression. B. Western analysis of
RNH1 expression (RNH1) in control (siCtrl) and RNH1 depleted 293T cells (siRNH1). α
Tubulin is shown as a loading control. Molecular weight in kilodaltons is marked to the
right for reference. C. Quantification of the DNA:RNA immunoprecipitation (DIP) signal
shown as a percent of input in siCtrl and siRNH1 293T cells. Pre-treatment of lysate
with in vitro RNaseH (In vitro RNAH) enzyme serves as a control for RNA:DNA hybrids.
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IgG is a non-specific antibody whereas S9.6 is a RNA: DNA hybrid-specific antibody.
Analysis of 3 technical repeats from a representative experiment is shown. p values
were computed using a 3-way ANOVA’s Sidak’s multiple comparisons test (*, p<0.05).
Error bars represent standard error of the mean. D. Representative images of S9.6
immunofluorescence on RPE1 control (siCtrl) and RNH1-depleted (siRNH1) cells. Blue
staining marks the nuclei and red is S9.6 signal (RNA:DNA hybrids). E. Quantification of
S9.6 signal (raw integrated density) (arbitrary units) for siCtrl and siRNH1 cells and
shown is one of three independent experiments where a minimum of 80 nuclei were
analyzed per sample. p values were computed using a non-parametric Mann-Whitney
test (*, p<0.05). Error bars represent standard error of the mean.
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Figure 3.3: RNH1 depletion results in replication fork slowing and increased
termination and stalling
A. Western analysis of RNH1 expression (RNH1) and H2AX phosphorylation (γ H2AX)
in RPE1 cells transfected with siCtrl and siRNH1. α Tubulin is shown as a loading
control. Molecular weight in kilodaltons is marked to the right for reference. B.
Schematics showing labeling of cells for microfluidic- assisted replication track analysis
(maRTA). Transfected RPE1 cells were labeled with base analogs CldU and IdU for 30
min each and subjected to the maRTA protocol and DNA visualization in red (CldU) and
green (IdU) by immunofluorescence (IF). Ongoing forks were marked by a red track
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(IdU) followed by green (CldU); terminated and/or stalled were red-only tracks; origin
firings were both green-only and red flanking green on either side. Representative DNA
tracks for siCtrl and siRNH1 samples are shown. C. A representative quantification of
three independent biological experiments showing the IdU track length (μm) preceded
by a CldU track. Analysis included a minimum of 260 two-color DNA tracks (moving
fork) isolated from siCtrl and siRNH1 cells each. p values were computed using a twotailed Student’s t test (*, p<0.05). Error bars represent standard error of the mean. D.
Quantification of percentage of termination and stalling events in DNA isolated from
siCtrl and siRNH1 samples. Mean from three independent experiments were analyzed
and each analysis included between 210 and 260 DNA tracks per sample. p values
were computed using a two-tailed Student’s t test (*, p<0.05). Error bars represent
standard error of the mean. E. Quantification of percentage of origin firings in DNA
isolated from siCtrl and siRNH1 samples. Graph represents combined means from
three independent experiments that included between 275 and 350 DNA tracks per
sample. p values were computed using a two-tailed Student’s t test (ns, p>0.05). Error
bars represent standard error of the mean.
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Figure 3.4: Nuclease activity of RNH1 is required for efficient replication fork
movement
A. Representative images verifying the nuclear localization (green) of ectopically
expressed RNH1 in 293T cells transfected with a GFP-tagged wildtype RNH1 (WT) or
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nuclease dead (D145N) allele. B. Western analysis of RNH1 expression (endogenous
and ectopic) in RPE1 cells transfected with a control siRNA (siCtrl) or RNH1-directed
(siRNH1) with or without ectopic expression of either GFP tagged wildtype (siRNH1+
WT) or nuclease dead (siRNH1+ D145N) RNH1. α Tubulin is shown as a loading
control. Molecular weight in kilodaltons is marked to the right for reference. C. A
representative quantification of three independent biological experiments showing the
IdU track length (μm) preceded by a CldU track. Analysis included 265 to 280 two-color
DNA tracks (ongoing fork) isolated from each of the four samples. p values were
computed using a one-way ANOVA with Bonferroni multiple comparisons test (*,
p<0.05; ns, p>0.05). Error bars represent standard error of the mean. D. Quantification
of percentage of termination and stalling events in isolated DNA from all four samples.
Mean from three independent experiments were analyzed and each analysis included
between 240 and 350 DNA tracks per sample. Error bars represent standard error of
the mean. E. Quantification of percentage of origin firings in DNA isolated from all four
samples. Graph shown represents combined means from three independent
experiments that included between 225 and 250 DNA tracks per sample. Error bars
represent standard error of the mean.
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Chapter 4:
Conclusions and future directions
Shankar Parajuli

128

Conclusions
DNA replication and DNA repair are vital cellular processes that maintain genome
stability. While numerous redundant mechanisms have evolved to ensure that these
processes are faithfully executed, they are not immune to dysfunction and failure. When
severe, such problems can result in genome instability, cell cycle arrest, senescence,
and apoptosis (1), (2). Importantly, such manifestations are associated with a wide
range of human pathologies from autoimmune diseases and cardiovascular diseases to
muscular dystrophy and cancer. Therefore, understanding the molecular mechanism of
DNA replication and DNA repair is critical for better understanding human diseases and
developing therapeutics.

To that end, my thesis work uncovers novel functions of two DNA replication and repair
proteins. First, we show that human flap endonuclease 1 (FEN1), a structure specific
endonuclease, is required for maintaining telomere stability. In particular, FEN1 loss
elicits telomere fragility on the leading strand replicated telomere, a phenotype
uncharacteristic of a lagging strand protein. Second, we discover that human
ribonuclease H1 (RNH1), an RNA:DNA hybrid specific nuclease, facilitates nuclear DNA
replication. We propose that RNH1 accomplishes this by resolving RNA:DNA hybrids
that can present roadblocks to a moving replisome complex.

FEN1 limits telomere fragility on the leading strand
As described in chapter 2, we provide the first evidence that a lagging strand protein,
FEN1, functions in leading strand DNA replication by preventing leading strand-specific
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telomere fragility. This finding was in a stark contrast to a lagging strand specific
telomere phenotype that our laboratory had previously reported where FEN1 prevented
a sister telomere loss (STL) phenotype at the lagging strand (3), (4). Because
RNA:DNA hybrids form at the leading strand telomere, we proposed that the fragility
phenotype could be a result of a collision between the replication and transcription
machineries (5). To test this hypothesis, we chemically inhibited transcription and found
that telomere fragility was exacerbated suggesting that transcription was an important
element of the fragility phenotype at the leading strand. Furthermore, we also identified
that this phenotype was a result of RNA:DNA hybrids as evidenced by the rescue of the
phenotype upon ectopic expression of RNH1 in FEN1-depleted cells. Finally, we
showed that FEN1’s flap endonuclease activity, not its interaction with PCNA nor its gap
endonuclease and exonuclease activity, was required to limit leading strand telomere
fragility phenotype. Taken together, we propose a model wherein FEN1 limits leading
strand fragility by using its flap endonuclease activity to cleave the RNA:DNA hybrid
structures produced as a result of a replisome-transcription collision event.

Human RNH1 limits R loops and facilitates DNA replication
We report in chapter 3 a novel role of human RNH1 in the nuclear DNA replication.
While human RNH1 is required for mitochondrial DNA replication, its nuclear function
has remained unclear except at the telomere of ALT cells (6), (7). Given that RNA:DNA
hybrids were abundant in the nucleus and that these topological structures could pose a
challenge to a moving replication fork, we hypothesized that RNH1 loss may elicit
replication defects. Upon RNH1 depletion, we first found a DNA damage response and
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accumulation of RNA:DNA hybrids, suggesting that these structures are responsible for
inducing DNA damage. We also analyzed metaphase chromosomes and found that
RNH1-depleted cells had elevated levels of telomere loss in comparison to the control
cells. This result was not surprising because of the important roles that RNA:DNA
hybrids play to maintain telomere stability (8), (6), (9). This also suggested that this
could be a result of replication fork collapse at the difficult-to-replicate telomere
template. Thus, we proposed a hypothesis that RNH1 might be important in DNA
replication outside of telomeres. To test that hypothesis, we utilized a single molecule
DNA replication technique to examine DNA replication efficiency (10). We discovered
that the replication forks slowed significantly upon RNH1 depletion. Similarly, replication
termination and stalling events also increased upon RNH1 loss. Although we observed
significant DNA replication defects, we were surprised that cells failed to activate the S
phase checkpoint and cell cycle arrest in RNH1 depleted cells. This suggests that either
RNH1 depletion is not significant enough to warrant a checkpoint arrest or that the
RNH1 function is compensated by other ribonucleases. It is also possible that the check
point activation is at a level undetectable by our current tools.

Future Directions
Structure and physiology of telomere fragility
While telomere fragility results from several manipulations including TRF1 loss in mice
and FEN1 loss in human cells as described in chapter 2, its structure composition and
physiological relevance are largely unknown (11). First, to date, fragile telomeres are
only described as abnormal telomeres that appear as multiple or smeared telomeres as
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visualized on metaphase chromosomes. However, how such structures are formed and
what proteins decorate and stabilize them remain unclear. Because visualization of
some of the fragile telomeres using telomere specific PNA probes reveal a nontelomeric sequences interspersed between two or more telomeric sequences, one might
speculate such structures result from recombination between telomeric and non
telomeric DNA sequences. It is also possible that those non-telomeric sequences are
the sub-telomeric regions. Furthermore, whether such non-telomeric sequences are
sequences of the same chromosome or different chromosomes remains to be seen.
One way to address these questions would be to combine a telomere PNA FISH with a
sub telomere DNA FISH on metaphase chromosomes. Because of the currently
availability of chromosome-specific sub telomeric DNA probes, these experiments can
reveal whether fragile telomeres are a result of intra-chromosomal or inter-chromosomal
recombination or both (12). These experiments would also uncover if those nontelomeric regions are sub telomeric sequences. Similarly, a lot of these structural
identities of fragile telomeres could be revealed by a new generation of super-resolution
microscopy. Another important question to investigate telomere fragility is to further
explore the roles of RNA:DNA hybrids. Although we suggested that telomere fragility
induced upon FEN1 depletion is RNA:DNA hybrid-dependent as evidenced by rescue
upon ectopic RNH1 expression, we did not directly measure those levels. Future
experiment could employ S9.6, an RNA:DNA hybrid specific antibody, to carry out an
immunoprecipitation to directly measure hybrid levels.
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A second set of intriguing questions regarding telomere fragility revolve around its
physiological relevance. In other words, what is the significance of fragile telomere, if
any? To begin to address this broad question, we could begin to ask specific questions.
Are fragile telomeres stalled intermediates of a repair process? Or are these end
products of a failed repair? Similarly, why would a cell form such structures? Is it a
preferred damage state for cell survival? Some of these questions can be answered by
beginning to closely look at the repair systems. One way to do this would be to utilize a
genetic approach and knockdown or knockout proteins of both DNA replication and
repair. However, such genetic knockdown experiments should be conducted with proper
controls to avoid confounding results. For example, knockdown of Rad51, an essential
homologous recombination protein, led to an increase in telomere fragility (12). This is
counter-intuitive given telomere fragility is thought to be a recombination-dependent
phenotype. However, it turns out that Rad51 is also required for telomere replication
and capping. Furthermore, because telomere fragility occurs through several means as
discussed earlier, it is possible that the mechanism of formation of such structures may
dictate their physiological roles thereby further complicating attempts to discern such
structures. To understand if fragile telomeres were stable or transient structures, our
laboratory conducted a series of time-course experiments by utilizing low doses of
aphidicolin to induce telomere fragility. Our unpublished and preliminary data show that
this phenotype was rescued 48 hours later suggesting that cells have mechanisms to
repair or resolve such structures. However, whether these findings apply to fragility
induced by other mechanisms such as TRF1 loss remains to be seen.
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Regulation of RNH1 during DNA replication
Although we identified a novel function of RNH1 in DNA replication as discussed in
chapter 3, a lot remains unclear about how RNH1 is regulated and how it functions in
the nucleus. First, we show that RNH1 depletion slows down replication fork movement
and increases termination and stalling events but how RNH1 is assisting the replication
machinery is unclear. Is RNH1 always associated with the fork during replication? Or is
RNH1 recruited to assist the fork only when the RNA:DNA hybrids are encountered?
One way to address these questions would be to conduct an isolation of proteins on
nascent DNA (iPOND) technique (13). This technique allows for the labeling of nascent
DNA followed by the purification of all proteins associated with an active replication
complex. PCNA, as an essential DNA replication protein, can serve as a positive control
to identify if RNH1 behaves in a similar fashion. In fact, using iPOND, our preliminary
data show that RNH1 associates with a moving replication fork. Regardless of whether
RNH1 associates with an active replisome complex or not, identifying RNH1’s
interaction partners might shed light on how it is regulated.

Another important question revolves around how RNH1 functions in the nucleus to
facilitate DNA replication. Although we show that RNH1 depletion elicits several DNA
replication defects, how RNH1 does this is unclear. We only provide a correlation
between increased hybrid levels and replication defects upon RNH1 depletion. It is
possible that there could be indirect effects of RNH1 that we have yet to consider. One
way to address this would be to inhibit replication by using aphidicolin, for example, and
assess replication defects in control and RNH1-depleted cells. If replication defects we
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observed upon RNH1 depletion are indirect effects, we can test a possibility that RNH1
may work together with other nucleases to co-ordinate its function. Furthermore, it is
worth exploring if depletion of other ribonucleases such as RNH2 or helicases such as
SETX and AQR would elicit such replication defects. This would require conducting
DNA replication studies as described in chapter 3 after depletion of these factors.
Lastly, understanding how a cell responds to RNH1 depletion and associated replication
defects can provide insights into its function. Because global DNA damage response is
observed upon RNH1 depletion as evidenced by increase in gH2AX, it will be interesting
to investigate the cell cycle checkpoint response. Examining checkpoint markers such
as Chk1, RPA, Chk2, ATM, and ATR may open insight into the cellular stress response
upon RNH1 depletion. It is possible that other nucleases or helicases discussed above
may compensate for RNH1 function thereby preventing checkpoint response.
Alternatively, accumulated hybrids upon RNH1 loss may be processed by DNA repair
system without invoking checkpoint response in a manner slightly different than
reported with hybrids that accumulate upon AQR depletion.
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